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Newborn infants are at risk of potentially life-threatening vitamin K deficiency 
bleeding. This is readily prevented with prophylactic vitamin K at birth. In New 
Zealand, the recommended route of prophylaxis is intramuscular (IM) but the uptake 
rates are lower than that of comparable countries. This study investigated the 
reasoning of parents who opted out of IM vitamin K prophylaxis for their newborn.  
Study Design 
Semi-structured interviews were conducted with fifteen families from the 
Otago/Southland region of New Zealand about their choice to opt out of IM vitamin K. 
Interview data was analysed using thematic analysis in order to elucidate themes 
capturing important aspects of parental decision making.  
Results 
Parents opt out of IM vitamin K for a variety of reasons. These were clustered 
into three main themes: parental beliefs and values, concerns about their child’s 
welfare, and external influencing factors. Parents also raised a number of concerns 
regarding other perinatal and childhood interventions.  
Conclusion 
This study identified factors that influence parental decision making, and lead 
to a decision to opt out of IM newborn vitamin K prophylaxis. These findings can 
contribute to the wider body of literature that informs public health initiatives 
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In 2013, seven infants were admitted to Vanderbilt Children’s Hospital in 
Nashville, Tennessee, with severe vitamin K deficiency1. Five of these infants were 
diagnosed with late vitamin K deficiency bleeding (VKDB) – four with intracranial 
bleeding, and one with gastrointestinal bleeding. Although all the infants survived, 
two required emergency neurosurgical evacuation of their haematomas, one has 
severe brain damage (cognitive delays and right hemiparesis), and two have mild to 
moderate neurological deficits. The parents of these seven infants had all declined 
vitamin K prophylaxis at birth for their children. Their reasons for doing so included: 
concern about an increased risk of leukaemia; a belief that the injection was 
unnatural, and unnecessary for uncomplicated births; and a fear that their infant 
would be exposed to toxins in the injection. Only one family was aware of the 
potentially life-threatening nature of VKDB1.  
The above occurred in the context of an increase in infants diagnosed with late 
onset VKDB in the region and a concern about an apparent rise in the rate of parents 
declining vitamin K prophylaxis in the surrounding community1. The same study 
reported that the rate of local parents declining vitamin K prophylaxis was 3.4%. This 
is double the rate of declining found in a recent New Zealand study (1.7%)2. However, 
when compared to older New Zealand data from another region, there is a suggestion 
that the number of New Zealand parents opting out of IM vitamin K has also 
increased in recent years3. 
In conjunction with this, there have recently been a number of studies 
regarding factors associated with opting out of IM vitamin K2, 4-6. However, it is 
unknown how these translate into parents’ thoughts, feelings and concerns about 
vitamin K prophylaxis. Additionally, although there is a growing body of literature on 
all aspects of vitamin K prophylaxis, very little of this data has been qualitative, with 







Aims of this Thesis  
This thesis is a qualitative, exploratory study on the attitudes, opinions and 
decision making influences of parents who choose to opt out of IM vitamin K for their 
newborn. It aims to address two key questions. Firstly, why do parents decline IM 
vitamin K prophylaxis? And secondly, when parents choose to opt out, how should 
healthcare professionals react? This thesis seeks to achieve these aims through the 
thematic analysis of interview data, and an analysis of this data using common ethical 
frameworks.  
Outline of this Thesis 
Each chapter of this thesis will address different aspects of the study.  
Chapter One contextualises vitamin K deficiency bleeding and the use of vitamin 
K prophylaxis, using the information gathered through an extensive literature review. 
It will explore: the history of VKDB and vitamin K prophylaxis, the controversies 
associated with vitamin K prophylaxis, and the current research regarding factors 
associated with opting out of IM vitamin K. Additionally, it will outline the decision 
making frameworks that will be discussed in chapter four. Chapter one contains a 
sizeable amount of technical information. Such information was considered salient to 
the review in order to provide sufficient context. For ease of reading the key points of 
such sections will be presented first.  
Chapter Two outlines the methods employed for this study.  
Chapter Three provides the main results of this research, including 
demographic information about the study participants, and a description of the 
themes elucidated from the study interviews. Quotations are included to illustrate 
key ideas.  
Chapter Four discusses the themes described in Chapter Three in depth. It 
places these in the context of the existing literature, including that related to similar 
childhood interventions such as newborn screening and immunisation. It also 
explores ethical questions that result from parents declining IM vitamin K 
prophylaxis.  










Michael Obladen’s “History of Haemorrhagic Disease of the Newborn” describes 
reports of spontaneous bleeding in otherwise healthy newborns as far back as 16827. 
Most of these were singular reports until hospitalisation allowed larger observations 
to be conducted, and by the end of the eighteenth century it was widely recognised 
that infants could, and did, bleed without experiencing any trauma7. Following this, it 
was Dr Charles Townsend at the Boston Lying in Hospital who coined the term 
‘Hemorrhagic Disease of the Newborn’ in 1894 to describe fifty cases of spontaneous, 
transient, neonatal haemorrhages from the GI tract, umbilicus, skin, and seven other 
locations8. He noted that it was distinct from other causes of neonatal bleeding, such 
as haemophilia, due to: male and female infants being equally affected; the transient 
nature; and that it occurred only in early life8. 
Accounts of clinical cases similar to that described by Townsend continued in 
the following years, and the understanding of neonatal haemorrhagic disease was 
greatly enhanced by the discovery of the coagulation cascade in 19049. In the years 
following, Schwarz and Ottenberg noted that infants with haemorrhage had 
prolonged coagulation times, and concluded that impaired coagulation is the 
immediate cause of uncontrollable haemorrhages in the newborn10. Schloss and 
Commiskey measured coagulation time in infants with bleeds, and suggested that 
incomplete coagulation is the underlying cause11, and Whipple postulated that 
melenaa in infants occurred due to a lack of prothrombin12. 
Despite these advances the cause of the bleeding tendency remained unknown 
until the 1930s when Henrik Dam at the University of Copenhagen described 
haemorrhages in the skin and organs of chicks fed a diet from which cholesterol and 
other lipophilic molecules had been removed13, 14. Follow up investigations resulted 
in the isolation of a fat-soluble substance from hemp seed, alfalfa, and hog-liver that 
could reverse this bleeding tendency15. This active substance was subsequently 
                                                          





named vitamin K (for koagulation, the term for coagulation in German and 
Scandinavian languages).  
The following chapter will cover important aspects of vitamin K and vitamin K 
deficiency bleeding (VKDB), such as: an overview of vitamin K, including structure, 
function, and how it is measured in the body; a description of the vitamin K status of 
infants; a description of VKDB and its subtypes; a discussion of the use of 
prophylactic vitamin K to prevent VKDB; and a brief description of parental decision 









Vitamin K refers to a group of structurally similar fat soluble (lipophilic, 
hydrophobic) molecules with a common function (also called “vitamers”). In 1939 
Edward Doisy was able to elucidate the structure of vitamin K, and found that vitamin 
K vitamers share a common methylated naphthoquinone ring structure, but have 
different aliphatic side chains attached at the c3-position16. The two naturally 
occurring forms of vitamin K are phylloquinone (vitamin K1) and the menaquinones 
(vitamin K2).  
Figure 1: Structure of vitamin K117 
Figure 2: Structure of MK-4 (a form of vitamin K2)17 
 
Phylloquinone (vitamin K1) was the substance first extracted by Dam in the 
1930s. It consists of the naphthoquinone ring structure with a phytyl-side chain at 
the c3-position16. It plays a role in photosynthesis and is therefore available in the 
Key Points 
 Vitamin K is one of four fat soluble vitamins and is most commonly found in 
leafy green vegetables 
 Vitamin K is important for the correct formation of coagulation factors in the 
blood 
 Without sufficient vitamin K, people (including infants) are at risk of vitamin 






largest amounts in green, leafy vegetables such as kale, silverbeet, and spinach; 
certain legumes; and some vegetable oils18. Vitamin K1 is the primary source of 
vitamin K in the human diet19.  
Menaquinones (together known as vitamin K2), also consist of the 
naphthoquinone ring structure but their side-chain consists of a varying number of 
prenyl groups. The number of prenyl groups is used to denote the subspecies (MK-n). 
The most common menaquinone in the human body is MK-4 as it is synthesised from 
vitamin K1 in the pancreas, testes and arterial walls20. The major dietary sources of 
vitamin K2 are MK-4 from animal tissue such as meat, eggs, and dairy products; and 
MK-7 which is synthesised by bacteria during fermentation and is found in a number 
of fermented dairy and soybean products21.  
Vitamin K2 can also be synthesised by bacteria that reside in the human 
intestines (especially the Bacteroides group), but there is continued debate over 
whether this vitamin K is a significant source for humans19, 22. Additionally, there is 
some evidence of poor bioavailability of this intestinal source of vitamin K19. This is 
because bile salts are required for the effective absorption of vitamin K, as it is fat 
soluble, but these are not present in the colon23. Nevertheless, insufficient intestinal 
colonisation by bacteria, and the resultant decreased endogenous production of 
vitamin K, are still often mentioned to be contributors to clinically significant vitamin 
K deficiency19, 24, 25.  
Vitamin K1 is commercially manufactured for medicinal use under several 
brand names, but Konakion® is the brand used for newborn vitamin K prophylaxis in 
New Zealand26. There are also additional, synthetic forms of vitamin K which are used 
in various industries such as pet food (vitamin K3) and to inhibit fungal growth 






Figure 3: Konakion vitamin K27 
Chemical Function 
In the 1970s, forty years after Dam’s discovery of vitamin K, Suttie et al and 
Stenflo et al revealed its molecular function28, 29. They found that vitamin K is a 
cofactor in the conversion of glutamate (Glu) residues to gamma-carboxylglutamate 
(Gla) residues28-30. These Gla residues are then capable of binding calcium ions, which 
are required to function by the vitamin K dependent clotting factors - factors II 
(prothrombin), VII, IX and X31.  
Before vitamin K can serve as a cofactor in the human body it must first be 
reduced to vitamin K-hydroquinone. During the gamma-carboxylation of glutamate 
residues, vitamin K is converted into vitamin K epoxide32. It is then regenerated by 
the vitamin K epoxide reductase (VKOR). This reduction and subsequent re-oxidation 
of vitamin K, coupled with the carboxylation of Glu residues is called the vitamin K 
cycle32. Each vitamin K molecule is thought to be recycled in this manner ~1000 
times33. Certain medications, including antiepileptic drugs and warfarin derivatives, 
interfere with vitamin K metabolism34. As a result, the infants of mothers taking such 






Indices of Vitamin K Deficiency 
Various indicators of a patient’s vitamin K status are available. Three of the 
most common indices are summarised below. 
Prothrombin Time (PT) 
The traditional screening tests for vitamin K deficiency are based on 
coagulation assays such as prothrombin time (PT), and activated partial 
thromboplastin time (APTT). Both tests measure the time taken for blood to clot: PT 
is an indicator of the efficacy of the extrinsic pathway of the clotting cascade, and 
APPT is an indicator of the efficacy of both the intrinsic pathway and the common 
coagulation pathway. Functionally active vitamin K dependent pro-coagulation 














Figure 4: The coagulation pathways. Reprinted with permission from Biochemistry. 





Whilst these tests are relatively easy to perform, a lengthening in coagulation 
time is non-specific for vitamin K deficiency. A deficiency is usually confirmed by two 
or more of the four vitamin K dependent pro-coagulation factors (II, VII, IX and X) 
being reduced34. Otherwise, normalisation of PT (and coagulation factors) upon 
vitamin K administration is also considered confirmatory34. However, the PT test is 
insensitive as it only becomes prolonged once the concentration of prothrombin 
decreases below 50% of normal36. As a result, the usefulness of the PT test is limited 
to diagnosing overt vitamin K deficiency, and is not useful for diagnosing subclinical 
deficiency. 
Proteins Induced by Vitamin K Absence or Antagonism (PIVKA) 
When there is an insufficiency of vitamin K, non-functional versions of vitamin 
K dependent coagulation factors are created and released into the bloodstream. 
These are created due to the inability of the body to carboxylate Glu residues without 
a vitamin K cofactor. The collective term for these under-carboxylated coagulation 
factors is PIVKA (Proteins Induced by Vitamin K Absence or Antagonism).  
Assays developed to specifically detect undercarboxylated prothrombin 
(PIVKA-II) have proven to be useful to detect subclinical vitamin K deficiency in 
infants37. Additionally, the delayed disappearance of PIVKA species after 
administration of vitamin K, and normalisation of PT time, makes them useful to 
retrospectively confirm that a bleeding case occurred due to vitamin K deficiency34. 
However, a disadvantage of such assays is that a clear cut-off point to define a 
clinically relevant degree of deficiency is difficult to determine36, 37. 
Plasma Levels of Vitamin K 
The most common circulating form of vitamin K in plasma is phylloquinone 
(vitamin K1) and its measurement in the blood is a useful indicator of vitamin K 
status and absorption. As the presence of circulating phylloquinone fluctuates with 
recent intake, serum concentrations should be determined after an eight hour fast. In 
healthy (adult) controls, fasting reference values of vitamin K range from 0.2 to 1.0 
µg/l with a median of around 0.5 µg/l, and dietary restriction of vitamin K leads to a 






Vitamin K Status of Infants 
 
Coagulation Factors 
The plasma concentrations of vitamin K dependent coagulation factors in 
infants are 40-60% of the normal adult values and slowly rise during infancy, before 
finally attaining adult values around six months of age40. The infants in such studies 
had all received 1mg of vitamin K by IM injection at birth, hence it is thought that the 
low concentrations of coagulation factors are caused by an overall reduced synthesis 
of the proteins, rather than an absence of the vitamin K cofactor34. However, it is 
generally accepted that if vitamin K is not given at birth, vitamin K dependent 
coagulation factors may fall during the first week of life. This results from work in the 
1960s by Aballi and de Lamerens, who reviewed studies on the course of 
prothrombin activity in breast-fed infants not given vitamin K at birth41. They found 
that prothrombin activity falls rapidly after birth to its lowest point on the second or 
third day of life, before returning to its initial concentration by day six. It is thought 
that this decrease results from a nutritional deficit of vitamin K in early life41. 
Further evidence of the lack of coagulation factors in infants is that PIVKA are 
found to be above normal levels in umbilical cord blood. One study with full-term 
infants in Japan reported a prevalence of detectable PIVKA-II in ~20% of infants42, 
and a similar amount was also reported in a study of pre-term babies in England43. 
Additionally, the use of PIVKA-II assays has shown that some infants still have 
Key Points 
 Vitamin K stores are low at birth, and only small amounts appear to cross the 
placenta (maternal: foetal gradient is between 20:1 and 40:1) 
 Coagulation factors in infants take up to six months to reach adult levels, and 
in the absence of vitamin K prophylaxis may fall on day two or three of life 
before increasing again by day six 
 Breastmilk has lower amounts of vitamin K than formula (due to formula 
fortification) 







inadequate vitamin K at one and two months of age, and that an increased presence 
of PIVKA-II in plasma is associated with both exclusive breast feeding, and omission 
of vitamin K prophylaxis at birth44, 45. 
Plasma Concentrations and Tissues Stores 
Phylloquinone (vitamin K1) is the largest contributor of vitamin K for the 
human foetus and neonate46. This is evident as menaquinones are present in low 
quantities at birth and take a number of weeks to build up, despite making up over 
90% of vitamin K reserves in adults46. Additionally, the concentration of vitamin K in 
cord blood is low compared to the concentration in adult plasma - the best estimates 
of the maternal/foetal vitamin K concentration gradient are between 20:1 and 40:146. 
However plasma phylloquinone concentrations are usually detectable in exclusively 
breast-fed infants from as early as twelve hours after birth, and by three to four days 
are within the same range as adults46. The low amount present at birth, and the time 
taken to build up stores of vitamin K, means that liver stores of vitamin K in infants 
are low in comparison with adults. This slow build-up of stored vitamin K2 is 
potentially consistent with the time taken for bacteria to colonise the infant’s 
gastrointestinal system34. Although, as previously mentioned, there is debate over the 
importance of bacterial-synthesis of vitamin K2 for human nutrition. 
Vitamin K Contents of Breast and Formula Milks 
Exclusive breast-feeding is a common risk factor for both idiopathicb and 
secondary VKDB47. It was first noted in the 1930s that cows’ milk offered protection 
to infants from spontaneous haemorrhage48. This led to work by Dam et al who 
measured the vitamin K content of human and cow milks. This work resulted in 
values of 15µg/l for breast milk, and 60 µg/l for cows’ milk49. These values became 
widely cited in the literature34, and in 1971, the American Academy of Pediatrics used 
them as the basis for their recommendations for the fortification of infant formulas50. 
Later assays showed that Dam’s values were an overestimate, and gave values of 2.1 
µg/l from mature human milk, 2.3µg/l from human colostrum, and 4.9 µg/l in 
Friesian cows’ milk51. A later study, using standardised techniques, found that human 
hind milk had a higher concentration of vitamin K1 than foremilk52. It also found that 
                                                          





the highest median value of vitamin K1 was in milk produced on the first day of 
lactation (median value 2.7µg/l)52. 
As a result of the fortification of infant formula, VKDB typically occurs in 
exclusively breastfed infants3, 53. In 1991, Greer et al compared the average daily 
dietary intakes of vitamin K1 of exclusively breast-fed infants and infants fed typical 
formula milk. They found that although no infants demonstrated obvious vitamin K 
deficiency, plasma vitamin K1 concentrations in the infants fed human milk remained 
low during the first six months of life (mean <0.25µg/l) compared to formula fed 
infants (mean values 5.99µg/l at six weeks and 4.39µg/l at six months)54.  
Von Kries, et al showed that vitamin K status is related to the infant’s total 
intake of breastmilk in the first week of life55. In this study, exclusively breast-fed 
infants who had increased PIVKA-II, and prothrombin activities of <25% of normal, 
were shown to have received less than 100ml of milk per day for the first four days of 
life. Conversely, infants with prothrombin levels >25% of normal on day five, had 
increased their average breast milk intakes to >100ml per day by days three and 
four55. Motohara et al showed similar findings in that a total intake of 500ml of breast 
milk during the first three days of life was sufficient for complete gamma-






Vitamin K Deficiency Bleeding (VKDB) 
 
Overview 
In 1999 the Pediatric/Perinatal Subcommittee of the International Society on 
Thrombosis and Haemostasis (ISTH) recommended a change in name from 
Haemorrhagic Disease of the Newborn (HDN) (as coined by Townsend in 1894) to 
Vitamin K Deficiency Bleeding (VKDB). The name change was in order to clarify that 
the etiological basis was solely due to vitamin K deficiency and to include infants who 
develop VKDB beyond the four week neonatal period57. 
In 1985, Lane and Hathaway described the three patterns of VKDB, which are 
stated below47. These descriptions are still widely accepted and are recognised by the 
ISTH Pediatric/Perinatal Subcommittee57. It is also usual to distinguish between 
idiopathic and secondary VKDB. In secondary VKDB there is a known underlying 
cause, this is usually a previously undiagnosed disease such as a congenital 
hepatobiliary or malabsorptive disorder, or an effect of drugs given to the mother or 
infant47.  
Several countries participating in surveillance programmes for VKDB, including 
the Netherlands, Germany, Australia, and Switzerland, have agreed upon 
standardised case definitions of VKDB to allow for international comparison58, 59. 
Key Points 
 VKDB is separated into three patterns of onset: early, classical, and late 
 Early VKDB occurs during the first twenty-four hours of life, and is typically 
seen in the infants of mothers taking drugs that interfere with vitamin K 
metabolism 
 Classical VKDB occurs during the first week of life. It is normally not life 
threatening and affects 1.24/100,000 live births in New Zealand. It typically 
affects exclusively breastfed infants who did not receive vitamin K at birth 
 Late VKDB occurs between eight days and six months of life. It affects 1.4-
2.83/100,000 live births in New Zealand. Intracranial haemorrhage occurs in 






Accordingly, a confirmed case of VKDB should fulfil the criteria of having a PT that is 
≥4 times the control value, and at least one of: 
1. Platelet count normal or raised, and normal fibrinogen, with absent fibrin 
degradation products 
2. PT returns to normal after vitamin K administration 
3. Concentration of PIVKA proteins exceeds normal controls  
The most recent surveillance data from New Zealand used similar criteria. In 
this study VKDB was defined as ‘spontaneous bruising or bleeding associated with 
prolonged clotting time, but not due to an inherited coagulopathy or DIC, in an infant 
<6 months old’3. Cases that met this criteria were reported to the surveillance unit 
and were confirmed by: the presence of a raised PT time, or international normalised 
ratio (INR); a normal fibrinogen level and normal or raised platelet count, and 
correction of the PT and bleeding after administration of vitamin K3. When this study 
was undertaken, the tests for PIVKA were not routine in New Zealand hospital 
laboratories, so this measure was not used.  
Early VKDB 
Early VKDB is bleeding due to vitamin K deficiency in the first twenty four 
hours of life. It indicates that vitamin K was deficient at birth, usually due to vitamin 
K deficiency in the mother. Early VKDB is rare and is typically seen in conjunction 
with the maternal use of drugs that interfere with vitamin K metabolism, such as 
anticoagulants (warfarin and derivatives), anticonvulsants (phenytoin), and 
antituberculosis drugs (rifampicin, isoniazid)34. There is no data on the incidence rate 
of confirmed early VKDB in New Zealand, and in the most recent surveillance study 
only three potential cases were reported between 1998 and 20083.  
Despite being rare, early VKDB is frequently life threatening due to the common 
bleeding sites/types. These include the head (cephalhaematoma and intracranial), 
intrathoracic, intra-abdominal, and gastrointestinal47. It has been stated in the 
literature that it may be more appropriate to classify idiopathic early VKDB 
separately from cases caused by maternal drugs. This is because classifying early and 
classical VKDB separately is not always considered necessary as idiopathic early 





Ethiopian hospital, the mean age of onset for early VKDB was twenty hours and the 
clinical features were identical to those found in infants diagnosed with classical 
VKDB60.  
Classical VKDB 
The bleeding tendency described by Townsend in 1894 is now recognised as 
classical VKDB. Classical VKDB occurs during the first week of life, and the most 
common bleeding sites are gastrointestinal, umbilical, skin, nose, and wound post-
circumcision47. Intracranial haemorrhages may also occur, but are rare47. The timing 
of classical VKDB is relatively well understood and the typical window of 
presentation between days two and three of life corresponds to the previously 
mentioned natural decrease in prothrombin activity.  
The most recent New Zealand surveillance report regarding VKDB reported 
eight confirmed cases between 1998 and 2008, with an overall incidence rate of 1.24 
per 100,000 births (95% confidence interval 0.54-2.45)3. None of these infants had 
received vitamin K prophylaxis at birth, and all but one were exclusively breastfed. In 
New Zealand the majority of infants are given vitamin K prophylactically at birth, 
however using unpublished data on the number of infants for whom prophylaxis is 
withheld, the surveillance unit reported the incidence of classical VKDB to be 69 per 
100,000 births, or 1 in 1439, for infants who did not receive vitamin K prophylaxis3.  
Comparing the incidence of classical VKDB between countries is complicated by 
differing study designs but a surveillance study from England reported the overall 
incidence of VKDB as 0.64 per 100,000 births61, and a study from Canada reported an 
overall incidence of 0.45/100,000 births62. Additionally, the historically suggested 
incidence of classical VKDB is between 1 in 60 to 1 in 400 breastfeed babies not given 
vitamin K63 – a much higher rate than that suggested by the New Zealand surveillance 
data. A number of reasons have been hypothesised for this lower rate3. They include:  
 New Zealand babies are not all exclusively breastfed, although breastfeeding 
rates are high 






However, it is still evident from this study that classical VKDB remains a 
concern for infants not given vitamin K prophylaxis at birth in New Zealand.  
Late VKDB 
Late vitamin K deficiency bleeding encompasses bleeding that occurs between 
eight days and six months57, with the peak incidence generally occurring between 
three and eight weeks of age64-66. Late VKDB almost exclusively occurs in breastfed 
infants, and occurs at a time when breastfeeding has been well established67. The 
mothers of affected infants usually have normal concentrations of vitamin K in their 
breastmilk, thus most late VKDB cases are unlikely to be due to insufficient intake67.  
Late VKDB is relatively rare, with an incidence in New Zealand of between 1.4-
2.83 per 100,000 births3. In a 2009 review of vitamin K deficiency bleeding, the 
incidence rates of late VKDB reported in other developed countries ranged between 0 
and 7.2 per 100,000 infants with the lowest rates occurring in countries with IM 
prophylaxis regimens (0, 0 and 0.3 per 100,000 infants)34. Despite being uncommon, 
when late VKDB does occur it is usually severe. Intracranial haemorrhages are 
present in 50-80% of reported cases and as a result, it is often associated with 
significant morbidity and mortality3, 68-71. However, “warning bleeds” often occur in 
infants with intracranial haemorrhage from late VKDB68. These are non-life 
threatening bleeds that precede serious bleeding, and in one study were present in 
7/10 infants with intracranial haemorrhage caused by late VKDB68. 
Late VKDB can have similar etiology to classical VKDB (low milk intake, low 
vitamin K content of milk), but in many cases an underlying condition causing poor 
absorption is found3, 68. Current evidence points towards an association of late VKDB 
with hepatobiliary dysfunction34. Due to vitamin K being a fat soluble vitamin, its 
absorption by the body is dependent on the presence of bile salts and pancreatic 
secretions. Any reduction in the production and/or secretion of these may then result 
in vitamin K malabsorption and deficiency46. Shearer proposes that the apparently 
increasing number of infants with late VKDB and hepatobiliary disease is caused by 
the increasing use of multi-dose oral vitamin K prophylaxis regimens34. He suggests 
that while these regimes protect healthy babies, it exposes those with hepatobiliary 
dysfunction who may have impaired vitamin K absorption to some increased risk30. 





with late VKDB72. In New Zealand, liver disease was present in 6/9 infants diagnosed 






Prevention of VKDB 
 
Overview 
In 1939 Waddell and Guerry published that administration of vitamin K to 
infants shortly after birth could prevent the drop in prothrombin levels that occurs in 
the first week of life 73. A 1944 review published in the Lancet stated that 
administration of vitamin K to mothers immediately prior to birth had a similar 
effect, and stated that it is “probably advisable to give menaphthonec either to every 
mother at or just before the beginning of labour or to every newborn child as a 
prophylactic against haemorrhagic disease”74. Also in 1944, the first trials 
investigating the usefulness of the prophylactic administration of vitamin K were 
published. In one trial, vitamin K was administered to the mother prior to birth, with 
variable results, and another was the first clinical trial investigating the 
administration of vitamin K to newborns immediately following birth75. The version 
of vitamin K used in these trials was menadione, and while some infants still bled, a 
1mg dose was shown to significantly reduce the incidence of bleeding between one 
and seven days of life75. Despite there being no biochemical confirmation that the 
breakthrough incidences were due to vitamin K deficiency, it was assumed that the 
dose used had been insufficient to protect all infants and as a result massive doses of 
up to over 30mg began to be given to infants7.  
Tragically, in the 1950s it became clear via a series of case reports that the 
administration of menadione could result in kernicterus and haemolytic anaemia, 
                                                          
c Menaphthone is a synthetic variant of vitamin K and is also known as menadione or vitamin K3 
Key Points 
 Intramuscular (IM) vitamin K prophylaxis at birth provides infants with 
almost complete protection against VKDB 
 Oral prophylaxis generally offers less protection than IM. 
Internationally, oral regimens differ in both the timing of 
administration and the protection offered 
 Infants with liver disease who are given oral vitamin K prophylaxis may 






particularly in preterm infants, and particularly with doses as high as those used76-78. 
Mary Crosse reported a series of sixty premature infants with kernicterus within ten 
years: “In 1947, at a total dose of 1-2mg, kernicterus occurred in 0.8% of preterm 
infants. In 1949, at a dose of 10mg, the incidence was 1.6%, and in 1953 the incidence 
rose fourfold [to 4.1%] when the dose of vitamin K was increased [to >30mg]”77.This 
effect was noted when menadione was used, but did not occur with other variants of 
vitamin K. This resulted in a more restricted use of vitamin K, followed by a 
subsequent increase in the incidence of VKDB79. It also resulted in phylloquinone 
(vitamin K1) become the vitamin K variant most commonly used for prophylaxis, and 
this is still the variant used in most developed countries.  
In New Zealand, the Ministry of Health recommends that all babies should 
receive vitamin K prophylaxis26. The recommended route of administration is 1mg 
intramuscularly at birth, or preterm infants may receive 0.5mg. The vitamin K used in 
New Zealand is Konakion MM® (2mg/0.2ml). If parents do not agree to an IM 
injection, the alternative is for the infant to receive Konakion MM®, 2mg orally at 
birth. The infant should then also receive a repeat 2mg oral dose at three to five days, 
and another at four to six weeks of age26. Uptake rates of vitamin K prophylaxis for 
the whole country are unknown, however data from a single tertiary birthing unit in 
Otago between 2009 and 2012 gave an uptake of 92.9% IM prophylaxis, 5.4% oral 
prophylaxis, with only 1.7% declined2. There is evidence that oral vitamin K is 
becoming more popular, with its use potentially more than doubling since 2008. This 
is based upon comparing the aforementioned study with unpublished vitamin K 
uptake rates from another New Zealand tertiary birthing centre between 2002 and 
2008 that are mentioned in a surveillance study of VKDB in New Zealand3. This 
surveillance study stated that 95.9% of infants received IM vitamin K, 2.3% received 
oral, and 1.8% refused prophylaxis3.  
Due to the inability to predict which infants are at risk of VKDB, nearly all 
developed countries have implemented prophylactic vitamin K programmes. As a 
result we are able to compare uptake rates in New Zealand to similar countries. Data 
from New South Wales, Australia between 2007 and 2009 shows a higher rate of IM 
prophylaxis uptake (96.3%), and corresponding lower rates of oral prophylaxis, and 





2012 showed much higher rates of IM prophylaxis (99.3%) and a rate of only 0.4% 
for oral prophylaxis, and only 0.3% having declined altogether4.  
Efficacy of Vitamin K Prophylaxis 
The implementation of vitamin K prophylaxis and VKDB surveillance 
programmes in many developed countries allows for comparison between different 
vitamin K regimens. Ideally the efficacy of a prophylaxis regimen would be confirmed 
in a randomised control trial (RCT). However, the low incidence of VKDB, and the 
ethical issues of carrying out an RCT on an intervention already shown to be 
protective, means it is unlikely that such a trial will ever be performed. Hence data on 
the efficacy of various regimens are mostly deduced from surveillance studies.  
Surveillance studies typically estimate the incidence of a disease by asking 
doctors to report potential cases. In New Zealand, a surveillance study of VKDB was 
done by including it on the New Zealand Pediatric Surveillance Unit card between 
January 1998 and December 20083. The patients’ information and files are then 
reviewed to confirm or exclude potential cases using the definition of VKDB 
described earlier. The number of confirmed cases of VKDB is then divided by the 
number exposed in order to estimate the incidence. For VKDB the number exposed is 
typically the number of live born infants during that time. However, the number of 
infants given a certain method of prophylaxis or who refused prophylaxis can also be 
used to estimate the efficacy of different regimens. The major assumption made by 
surveillance studies is that there is a direct, and inverse, relationship between the 
incidence of VKDB and the efficacy of a prophylaxis regimen. Additionally, they 
assume that other factors including the rate of reporting and recognition, as well as 
risk factors, are comparably present in populations. The surveillance study of VKDB 
from New Zealand recognised some of these shortfalls as it stated that a lack of 
recognition of VKDB (as it is a rarely seen disorder), or a lack of referral to a 
paediatrician would mean that some cases may not have been captured in the study3. 
In 2000 Wariyar et al compared the incidences of late VKDB in various 
countries with differing prophylaxis regimens80. Their results are shown below in 
Figure 5. The differing incidences that occur in countries with no prophylaxis is 
potential evidence that the assumptions listed above may not be true for all studies. 





VKDB, a single oral dose is not effective in preventing late VKDB, and the efficacy of 
oral prophylaxis is improved by increasing the number of doses. More recent data 
also supports the administration of prophylactic vitamin K - in the New Zealand 
VKDB surveillance study published in 2011, all but one of the VKDB cases had refused 
prophylaxis3.  
It has been suggested that the long-term efficacy of IM vitamin K is due to a 
depot mechanism, where vitamin K is absorbed slowly over many weeks81. In 
support of this theory, PIVKA in one month old infants given IM vitamin K are 
normally undetectable, and one study showed that the proportion of one month old 
infants with detectable PIVKA was similar whether the infants were given one dose of 
oral vitamin K at birth, or no prophylaxis45. Additional support for this theory comes 
from the observation that IV administration of vitamin K also does not offer long term 
protection against late VKDB, even when given in higher doses than would be given 
via IM administration82. 
Figure 5: Incidence of VKDB under various prophylactic regimes (Reprinted 





     Despite evidence that oral prophylaxis is not as effective as IM prophylaxis, in the 
early 1990s it had a surge in popularity due to concerns that IM vitamin K was 
associated with childhood cancer (see later). As a result, paediatricians in a number 
of countries with VKDB surveillance programmes initiated assessments of the oral 
prophylaxis regimens used at the time59, 83. Germany and Australia both originally 
followed a three-dose oral regimen with 1mg of phylloquinone given at birth; days 
four to ten; and days twenty-eight to forty-two, or days twenty-one to twenty-eight, 
respectively. The total incidence of late VKDB under these regimens was low (2.6 and 
2.5 per 100,000 births respectively) but it was still higher than the incidence in 
infants given IM prophylaxis59. In Germany, the oral dose was increased to 2mg in a 
three dose regimen (almost identical to what is currently used in New Zealand), and 
this resulted in a decrease in the incidence to 0.72 per 100,000 live births and 0.44 
per 100,000 infants who had received all recommended vitamin K prophylaxis 
doses72. Further research from the same group regarding the mixed micellar 
preparation of vitamin K (the version currently used in New Zealand) showed that 
the incidence of late VKDB was 0.44 per 100,000 infants compared to 0.72 per 
100,000 infants given other preparations84. The regimen followed by Denmark at the 
time was a single oral dose of 1mg of vitamin K at birth. The incidence of late VKDB 
under this program was calculated as 4.5 per 100,000 infants85. However when 
Denmark later changed to giving a 2mg oral dose of vitamin K at birth followed by a 
1mg oral dose weekly for the first three months of life, no cases of any form of VKDB 
were reported during the seven year observational period86. Hence, while there is 
still debate over which method of oral prophylaxis is best, the three-dose oral 
schedule currently used in New Zealand appears to be one of the most effective87. 
Nonetheless, IM prophylaxis remains the recommended route of administration in 
New Zealand due to its increased efficacy, although parents are able to choose the 






Barriers to Successful Vitamin K Prophylaxis 
A number of barriers to the successful implantation of prophylaxis regimens 
have been identified. These range from factors affecting the efficacy of regimens, to 
parents refusing vitamin K prophylaxis for their child. In this section I will describe 
such factors, starting with the association between liver disease and oral prophylactic 
failure; then describing the previously mentioned controversy regarding IM vitamin 
K prophylaxis and childhood cancer; then finally describing more recent research 
about factors that are associated with parental refusal of vitamin K. 
Oral Prophylaxis and Liver Disease 
As described above, most oral prophylaxis programmes are less effective at 
preventing VKDB than IM prophylaxis. From surveillance studies, a number of 
indicators of prophylaxis failure have been identified. These include: exclusive 
breastfeeding; non-compliance to the oral regimen; and more commonly, an 
unidentified, underlying absorptive disorder, of which cholestatic liver disease is the 
most common53, 72, 84, 87, 88.  
Cholestatic liver disease and other absorptive disorders can affect the 
functioning of the liver, and the production of bile. As previously discussed, vitamin K 
is a fat soluble vitamin that requires bile salts in order to be absorbed, thus when 
affected by such disorders, vitamin K is less able to be absorbed from the 
gastrointestinal tract34. This suggests the lesser protection offered by oral vitamin K 
prophylaxis is at least partially due to the inability of some infants to absorb it. 
Vitamin K and Childhood Cancer 
In 1990, Golding et al published a study in the British Journal of Cancer about 
factors associated with childhood cancer in a national cohort study89. One of the 
findings was an association of childhood cancer with vitamin K administration which 
was “unexpected and fitted no prior hypothesis”89. Only one newspaper, the 
Guardian, published any mention of this study (on August 2 1990)34.  
Then almost two years later, on May 7 1992, the Daily Mail ran a front page 
headline that read “Vitamin Link to Child Cancer” and the next day a number of 
newspapers ran articles on the story34. It became evident that the story had leaked 
from a supposedly closed paediatric meeting where Golding had presented 





vitamin K and cancer. Golding’s findings were published in August 1992 – they 
reported that the risk of leukaemia in children given IM vitamin K at birth was almost 
double (odds ratio 1.97) but there no increased risk when vitamin K was given 
orally90. This resulted in the British Pediatric Association reviewing their policies and 
recommending the routine use of oral vitamin K prophylaxis in healthy newborns 
with IM prophylaxis reserved for those thought to be at the most risk of VKDB91. 
There was also a resultant decrease in the use of IM prophylaxis - in 1988 58% of 
newborns were routinely given IM vitamin K in Britain and this fell to 38% in 1993, 
the year after Golding’s paper was published91. 
Golding’s study was the catalyst for a number of studies in numerous countries 
that tested the association between vitamin K and cancer. Nine studies were carried 
out between 1992 and 1998, and only one found a potential link. That study 
suggested that IM vitamin K was associated with an increased risk of developing 
acute lymphoblastic leukaemia one to six years after birth (odds ratio 1.79)92. In 
1999 a working group of the WHO International Agency for Research on Cancer 
(IARC) reviewed the available literature and concluded that there was “inadequate 
evidence in humans and experimental animals for the carcinogenicity of vitamin K 
substances”93. Following this publication, in 2002 and 2003 the two most extensive 
studies on the topic were published. In 2002, Roman et al. combined data from six 
major case-control studies94. In total 2,431 children with cancer and 6,338 children 
without cancer were included in the studies, and they concluded that the “analysis 
provides no convincing evidence that intramuscular vitamin K is associated with 
childhood leukaemia”94. In 2003, Fear et al. published an even more comprehensive 
study. They included 2,530 children with cancer (1,174 of whom had leukaemia) and 
4,487 children without cancer. 39% of the children with cancer and 42% of the 
controls had received IM vitamin K95. The study concluded “that there is no 
convincing evidence that neonatal vitamin K administration, irrespective of the route 
by which it is given, influences the risk of children developing leukaemia or any other 
cancer”95. 
While fears surrounding leukaemia and IM vitamin K have eased since Golding’s 
original papers were published, there is evidence that it still affects the attitudes of 





Zealand published in 2014 showed that some midwives have concerns that 
prophylaxis may be associated with cancer96, and in the report mentioned earlier 
regarding infants with VKDB in Tennessee, the risk of leukaemia was given by some 
parents as the reason why they declined vitamin K1. There is an abundance of 
information available to parents online about vitamin K prophylaxis (a Google™ 
search for “vitamin K injection” brings up 1.4 million results) and it is a topic that is 
often mentioned by blogs and online pregnancy/motherhood forums.  
Other Factors Potentially Impacting Vitamin K Uptake 
A number of factors have recently been associated with declining IM vitamin K 
prophylaxis. In a study from Canada, where having a midwife-assisted birth is rare 
(3% of births), it was found that births attended by midwives were eight times more 
likely to be associated with vitamin K refusal compared to physician-attended 
deliveries (risk ratio 8.4)4. The same study found planned home deliveries and 
deliveries in birth centres were also more likely to be associated with vitamin K 
refusal (risk ratios 4.9 and 3.6 respectively)4. Additionally, this study found that 
parents who refused vitamin K were fourteen times more likely to refuse childhood 
vaccinations at fifteen months of age (relative risk 14.6)4.  
This data is supported by three recent studies – two from New Zealand and one 
from Australia. The first study from New Zealand found a risk ratio of 14.1 for non-
immunisation in babies whose parents had refused vitamin K at birth, and a risk ratio 
of 3.5 for non-immunisation in babies whose parents had chosen oral vitamin K 
administration6. The second study from New Zealand identified a number of perinatal 
influences on the uptake of vitamin K prophylaxis. This study found that refusal of 
vitamin K was associated with being of Asian ethnicity (odds ratio 5.87); having a 
vaginal delivery (odds ratio 2.85); and greater gestational age, per week (odds ratio 
1.24)2. The same study found Asian ethnicity to also be associated with oral vitamin K 
prophylaxis (odds ratio 2.61), in addition to: having an obstetric nurse as Lead 
Maternity Carer (LMC) (odds ratio 2.65); vaginal delivery (odds ratio 2.34); and 
gestational age, per additional week (odds ratio 1.14)2. Interestingly, it was also 
found that with increasing LMC experience was associated with parents being more 
likely to accept IM vitamin K as LMC experience, per decade, was associated with 





The third study, from Australia, also described maternal and infant 
characteristics by mode of vitamin K prophylaxis. They found that compared to 
infants who received IM vitamin K, those with oral or no prophylaxis were more 
likely to have mothers over thirty-five years (odds ratios 1.44 and 1.10 respectively), 
who had an analgesia free delivery (odds ratios 1.06 and 1.28 respectively)5. 
Additionally oral, or refusal of, prophylaxis was found to be associated with normal, 
vaginal birth; delivery in a birth centre (odds ratios 2.26 and 2.02 respectively); and 
planned home birth (odds ratios 5.50 and 23.52 respectively)5.  
The factors above which have been identified as being associated with opting 
out of IM vitamin K prophylaxis have also been described as being aligned with a 
more ‘natural’ birth without medical interventions2, 5. One study notes that this 
suggests that IM vitamin K prophylaxis is unappealing to parents who have concerns 
about the medicalisation of birth and of the risks of the injection5. However, despite 
these postulations, the exact reasons why parents choose to decline IM vitamin K 
remained enigmatic. Hence, this thesis aims to translate the factors associated with 
declining IM vitamin K into the actual thoughts and concerns of the parents who 






Parental Decision Making 
The second aim of this thesis is to identify how health professionals should 
react when a parent chooses to refuse IM vitamin K. Vitamin K prophylaxis, along 
with other interventions such as immunisation, represent an interesting paradox, as 
while parents are free to decline, the intervention is strongly recommended26. Ethical 
literature recognises the parents’ right to make decisions for their children, but also 
recognises that there is a limit to such rights97. The limit for New Zealand law is that 
when parents act in a manner where their child is being, or is likely to be, harmed, the 
state may intervene98. One issue with the concept of “harm” is that it is hard to 
quantify and differing levels of harm may be acceptable to different people. In order 
to try and clarify this, a number of frameworks can be used to evaluate whether a 
parental decision is one that justifies state intervention97, 99. In the discussion chapter 
of this thesis, the three frameworks described below will be discussed in detail with 
regards to vitamin K prophylaxis, and whether a refusal of IM vitamin K constitutes a 
decision that should be overridden.  
The Best Interests of the Child 
Clinicians have traditionally thought in terms of a child’s “best interests” when 
deciding how to act when parents make a choice for their child that is not in line with 
recommendations100. Consequently, the “best interest standard” has become the 
prevailing ethical standard used to determine when interference is justifiable100. 
Acting in a person’s best interests has been defined as “acting so as to promote 
maximally the good of the individual”101, and the best interest standard has been 
defined as one in which “. . .a surrogate decision maker must determine the highest 
net benefit among the available options, assigning different weights to interests the 
patient has in each option and discounting or subtracting inherent risks or costs”102.  
However, acting in a child’s best interests all of the time is an exceptionally high 
standard and one that is not applied to other parental decisions, such as place of 
residence and choice of school99. It also does not allow any interests to be taken into 
account other than those of the child who is getting treated, such as the interests of 
the parents or siblings – all of whom have to cope with any potential consequences 
from the decision made99. It is because of these criticisms that other decision making 





The Harm Principle 
According to the Harm Principle, parental decision making justifies interference 
if the decision will result in some harm to the child, rather than the decision not 
aligning with the child’s best interests97. In order to identify the level of harm that 
may be tolerated in parental decisions, Diekema has summarised various suggestions 
about the nature of the harm threshold97. He argues that parental decisions that do 
not significantly increase the likelihood of serious harm compared to other options 
should be tolerated, and that state intervention to overrule parents should only occur 
when a child is at probable significant risk of serious harm. As a result, the harm 
principle accepts decisions that are suboptimal for the child, as long as they are 
unlikely to result in, or cause, significant harm.  
The Zone of Parental Discretion 
The Zone of Parental Discretion is a concept developed by ethicists at the Royal 
Children’s Hospital Melbourne (Melbourne, Australia) as a tool to help consider if 
decisions made by parents should be accepted, even when they are not seen by 
medical staff to be in the child’s best interests99. It extends the idea of the harm 
principle to all situations where parents and clinicians may disagree, with the key 
idea being that clinicians can accept parental decisions that are suboptimal for the 
child, so long as the decisions do not involve probable significant harm99.  
With both the Harm Principle and the Zone of Parental Discretion, it is unclear 
what exactly the threshold of probable significant harm is, and how much risk of harm 
is acceptable. Thus vitamin K poses an interesting conundrum. As described earlier, 
the risk of an infant developing VKDB is generally low, and is difficult to accurately 
quantify for an individual. However when it does occur, the consequences of VKDB 






Objectives of this Thesis 
As described in the preceding chapter, there are a number of studies that 
describe factors associated with opting out of IM vitamin K prophylaxis. However, 
there have been no studies regarding vitamin K prophylaxis that identify parents’ 
specific concerns, or their reasons for opting out. Consequently the first objective of 
this study is to explore parents’ thoughts, feelings, and concerns regarding vitamin K 
prophylaxis and ascertain the specific reasons why they chose for their child not to 
receive IM vitamin K.  
The second objective of this study is to conduct an ethical analysis of parental 
refusal of IM vitamin K. The discussion of this thesis will use “ethical tools” to explore 
whether refusing IM vitamin K prophylaxis is a decision that should be overridden. It 
will also discuss how clinicians should act in such circumstances in order to both 
advocate for what is best for the child; and establish, or maintain, a positive 






Chapter Two: Methods 
 
 
In order to achieve the objectives of this study, qualitative research 
methodology was used to explore the perceptions, opinions, and influences of a group 
of parents who opted out of intramuscular vitamin K prophylaxis for their child. 
Semi-structured interviews were conducted with participants and the resulting data 
was analysed using thematic analysis. The details of how I collected, analysed and 
interpreted the data are described in this chapter, and I also introduce two key 
ethical questions that will be explored in the discussion chapter.  
Study Setting and Recruitment 
This study was conducted in the Otago/Southland region of New Zealand 
(population ~310,000). New Zealand has publically funded maternity and newborn 
healthcare, and the majority of births for this region occur at the Queen Mary 
Maternity Centre (QMMC), Dunedin Hospital (Dunedin, New Zealand), the only 
provider of tertiary maternity and newborn care for the region. There are eleven 
other birthing units in the region: one secondary level unit based at Invercargill 
hospital and ten that provide primary maternity services. In addition, approximately 
4.3% of births are planned to occur at home103.  
The key inclusion criteria for the study were:  
1. Delivery of a live-born child within the Otago/Southland region 
2. A parental decision to decline IM vitamin K prophylaxis for their newborn 
(either complete refusal of vitamin K or a choice of oral administration) 
3. Adequate English (or availability of an interpreter) for an interview 
After reviewing the literature and similar qualitative projects, my supervisors 
and I decided that fifteen interviews were likely to be an appropriate number to 
produce meaningful results. The number of interviews also had to be achievable 
within the time allowed for a BMedSc(Hons) project, particularly in light of the fact 
that only ~7% of births in the region involve a decision to decline IM vitamin K. 
During the course of the study it was confirmed that a sufficient degree of data 





be elucidated from the data. Recruitment occurred between 07/03/2015-18/07/15 
via a number of pathways, which are outlined below.  
As discussed in the previous section, it has been noted that there is an 
association between declining IM vitamin K prophylaxis and a preference for factors 
that are generally associated with “natural” childbirth, such as homebirth and 
declining immunisations2, 4, 5. Based on this, for initial recruitment I contacted three 
midwives who are strong advocates for homebirth in the Dunedin area in order to 
ensure that parents who chose to birth at home were well represented in the study 
cohort. I asked the midwives to talk about the study to expectant parents in their care 
who had chosen to decline IM vitamin K, and if they were interested, to pass their 
details on to me. I made contact with the referred parents and emailed them the 
study information sheet. If parents then consented to taking part, we organised a 
time and place for the interview. Four participants were recruited in this manner. 
Secondly, I contacted medical staff involved with newborn care at QMMC, this 
included those conducting new born baby examinations. As with the midwives, I 
asked them to talk to parents who had chosen to decline IM vitamin K and to pass 
their details on to me if they were interested in taking part. I made contact with the 
referred parents and gave them the study information sheet. If parents then decided 
to take part, we organised a time and place for the interview. Seven participating 
families were recruited using this method. For these participants, and the four 
participants recruited by home birth midwives, there is no way to know how many 
other potential participants the study was discussed with (the denominator of this 
recruitment method). However a previous study showed that approximately 125 
babies did not receive IM vitamin K at QMMC each year between January 2009 and 
December 2012 (503 in total)2. If we use this data to extrapolate, we could expect 
that approximately sixty infants in the region did not receive IM vitamin K during the 
five months that we were recruiting and hence the percentage of these families we 
recruited is 18% (11/60). 
Thirdly, invitation letters were posted to a random selection of forty-two 
mothers identified from electronic maternity records as having declined IM vitamin K 
prophylaxis between 01/01/2014-08/04/2015 at QMMC. QMMC keeps an electronic 





with data entered throughout the pregnancy, from demographic and health data 
collected at initial early pregnancy registration by administrative staff, to all 
pregnancy, labour and postnatal data collected by the LMC or hospital midwifery 
team. Vitamin K details are added to this system from signed consent and 
administration forms which are required in all instances of vitamin K administration 
(or non-administration). If parents wanted to take part in the study after receiving 
the invitation, they contacted me via email or phone in order to arrange a time and 
place for the interview. Three participants out of forty-two invitations (7%) 
contacted me and completed the study using this method of recruitment. 
Fourthly, one participant was recruited via a referral from another medical 
student who knew about the project I was conducting this year. They had a friend 
who had opted out of IM vitamin K for their children and they contacted the family 
about the study, who then decided they would like to take part. They gave permission 
for their contact details to be passed to me, I contacted them and we organised a time 
for the study interview. 
It may be important to note at this stage that unlike many studies there was no 
incentive offered to participants for taking part. This had positive aspects as it meant 
that participants were freely giving up their time because they were interested in the 
study and felt it was important, but also had negative aspects as participants were 
not offered anything for their time and I may have been able to recruit more 
participants in less time if I had been able to offer them a reward.   
Information about the participants is included in the results chapter.  
The Interview Process 
Semi-structured interviews were used to explore parental reasons for declining 
IM vitamin K for their newborn. The questions asked in the interviews centred on a 
number of key points that were developed through discussions with paediatricians 
and neonatologists, as well as interviews conducted with ten Dunedin midwives, as 
part of a prior University of Otago summer studentship completed by another 
student.   
The interviews conducted with midwives centred on the role of the midwife in 





included: how important they thought it was the parents knew about and gave 
vitamin K; their opinion on the Ministry of Health guidelines for vitamin K 
prophylaxis; how they inform parents; what parents already know about vitamin K 
and how they find information; common parental objections to IM vitamin K; and 
how they would improve the vitamin K guidelines. Their answers guided a number of 
the interview questions and ensured that issues central to newborn vitamin K 
prophylaxis were discussed in the interviews. 
The key points covered by my interview guide included demographic data for 
each participant (including mother’s age at interview and age at first child, ethnicity, 
address to identify their deprivation deciled, mother’s level of education, paritye, and 
marital status); an initial description of how they made their decision to opt out of IM 
vitamin K; when and how they first became aware of vitamin K; information, people 
and health professionals that influenced their decision; health professional reactions 
to opting out of IM vitamin K; concerns about giving vitamin K; cultural and religious 
issues regarding vitamin K prophylaxis; whether they felt any pressure to make their 
decision a certain way; alternative methods employed to prevent VKDB; and their 
views about other perinatal health interventions, including immunisation and 
newborn screening.  
The questions in the interview guide were worded to ensure they were not 
leading questionsf and were as open ended as possible. If participants gave an 
unclear, or particularly short answer as a response, I would ask them to further 
clarify or explain their answer. Words that were absolute, or had emotional 
connotations were avoided in the interview guide to ensure that the answers given 
by participants reflected their true opinions. The full interview guide is included in 
Appendix 1.  
The semi-structured approach to the interviews allowed extra questions to be 
asked in response to participants’ answers. This meant that any points mentioned as 
having an influence on a participant’s decision were able to be explored further, and 
that complex discussion regarding each topic could occur. The interview guide was 
                                                          
d A well described marker of socioeconomic status, according to the New Zealand Deprivation Index100   
e Parity is the number of pregnancies a woman has carried to over 20 weeks gestation 





not restrictive, but having a number of structured questions gave a framework for 
each interview and allowed for the generation of comparable data.  
The interviews were conducted over a period of five months. Nine were 
conducted face-to-face in the participants’ homes, one interview was conducted in 
hospital the day following the child’s birth, and five were conducted over the phone 
due to the geographical location of the participant. Eleven of the interviews were 
conducted with the mother alone and four had both parents present. All participants 
had the opportunity to ask questions about the study and gave their informed 
consent to take part.  
After the initial interviews had taken place, we had a number of additional 
questions inspired by the data gathered, and the participants were again contacted in 
regards to these. These extra questions are also included within the interview guide 
in Appendix 1. 
All interviews were audio-recorded using a digital voice recorder and 
transcribed to allow for analysis. Total interview times varied in length, the longest 
interview was seventy-five minutes and the shortest was eleven minutes. The median 
interview time was twenty-eight minutes and the mean was thirty-three minutes. 
This variation in time was due to the nature of the semi-structured interview guide 
and the differing reasons participants had for opting out of IM vitamin K. The shortest 
interview was also conducted with a family whose child had been born that week and 
they had limited time for the interview. Following the second round of interviews, my 
supervisors and I were satisfied that data saturation had been achieved 
In anticipation of subsequent thematic analysis I personally transcribed the 
interviews and each interview was listened to multiple times in order to ensure 
accuracy and familiarisation with the data. This process took between four and ten 
hours for each hour of recording as it was dependent on a number of factors. These 
included: speed of speech, accents, and background noise. It was made clear to the 
participants that the only people who would see the transcripts were myself and my 
supervisors. Any potentially identifying information was removed from the 





anonymity. The raw data, including transcripts and audio recordings have been 
stored according to University of Otago policies.  
Thematic Analysis 
Thematic analysis was used to identify themes from the interview data. 
Thematic analysis is a method to identify, analyse, and report patterns (known as 
themes) within data and allows researchers to provide a complex account of data 
gathered, usually via focus groups or a qualitative interview process104.  
In the following paragraphs I will describe the methodology of identifying, 
analysing, and reporting themes from the interview transcripts. An important 
informant to this part of my methodology was the paper Using Thematic Analysis in 
Psychology by Braun and Clarke104, as not only did it discuss instances in which 
thematic analysis should be used, but it provided a guide to effectively conduct it.  
Firstly, each interview was transcribed from the audio recording. This allowed 
me to both view the data set in a tangible way, and familiarise myself with it. During 
this stage, I was already able to begin to generate ideas about potential patterns in 
the data.  
Following transcription, the next step was to code the data. Coding is the 
process of moving the data into meaningful groups105. Some of these groups followed 
the questions asked in the interviews but there were also concepts that captured a 
seemingly important aspect of parental decision making but did not ‘belong’ to a 
particular question. It is important to note that identification of a potential theme was 
not dependent on how frequently it was brought up during the interviews104, but 
rather anything discussed in the interviews that represented a seemingly important 
aspect of parental decision making was explored.  
Following coding, the data was analysed further and key themes and subthemes 
were decided upon through an iterative process that included not only personal 
review by myself, but additional discussion between my two supervisors and I (one 
of my supervisors (NK) is a paediatric bioethicist and both are paediatricians 
experienced in newborn prophylactic vitamin K administration). These themes are 
presented and described in the next chapter of results along with quotes from the 





Reflexivity and Researcher Background 
Good research should be reflexive. This means that the researcher should 
regularly assess how they are conducting the research, and the role they are playing 
in the research process. Thus it is important to note that the development of themes 
requires personal judgement. It is possible that if the interview transcripts were 
reviewed by another person, or from a different theoretical position, that this may 
result in the development of alternative themes to those in this thesis106. Due to this, 
before the commencement of the results chapter which includes the outcomes of the 
thematic analysis, it is important to mention my background and how this may have 
influenced my interpretation of the data. I am a fourth year university student 
between my third and fourth years of medical school. This may have had some 
influence on how I engaged with participants and the themes I identified, however 
through the processes described above, every precaution was taken to prevent bias 
in this study. As a result I am not consciously aware of any effect my background had 
on the project. However, I am aware that it may impact how the information 
presented is perceived by others.  
Ethical Analysis 
In addition to presenting the results of the qualitative study described above, I 
will also examine the following two ethical questions related to IM vitamin K 
prophylaxis and parental decision making: 
1. Does parental refusal of IM vitamin K prophylaxis constitute the type of 
parental decision that should be overridden?  
2. If it shouldn’t be overridden (as is current practice) then how should health 
professionals respond to such a decision that from a standard medical 
perspective does not appear to be in the child’s “best interests”?  
These questions will be discussed using the ethical frameworks described in 
chapter one: The Best Interests Model, the Harm Threshold Model, and the Zone of 
Parental Discretion. These models will be used to distinguish whether parental 
refusal of vitamin K is a decision that should be overturned, and to inform a 






Ethics and Māori Consultation 
Ethics approval for this project was sought through the Health and Disability 
Ethics Committee (Ethics ref: 12/STH/41) and the project was approved on 29 
November 2012. Two post-approval amendments were sought after this date: the 
first was granted in December 2013, and the second was conducted and requested by 
myself, and granted in March 2015. This included substantial changes to the 
questionnaire and information sheet, and changes to recruitment that allowed me to 
invite parents whose children were born at QMMC between January 2014 and March 
2015. 
Maori consultation was conducted via an application to the Ngā Tahu Research 
Consultation Committee, and their approval was obtained.  






Chapter Three: Results 
 
 
The following chapter will describe the main findings from this research 
project. Firstly I will outline the study participants, including their demographic data. 
Participants have been anonymised and no identifying data will be provided. 
Secondly, I will illustrate the themes and subthemes of parental decision making 
regarding vitamin K prophylaxis that were identified from the thematic analysis.  
Participants 
Fifteen families were interviewed. Eleven interviews were conducted with 
mothers, and four had both parents present. Ten families had declined vitamin K 
prophylaxis for their newborn and five had chosen oral administration. Eight 
different ethnicities were represented in the study cohort.  
The mean age of mothers participating in the study was thirty-four years (range 
twenty-three to forty-five), and their mean age at the birth of their first child was 
twenty-nine years (range twenty-one to thirty-six). Nine interviews were conducted 
with families who had a child born in the previous twelve months and the median age 
of the families’ youngest child at the time of interview was nine months (range one 
day – thirteen years). The study population was highly educated, with ten mothers 
holding a Bachelor’s degree or higher. Five of the participating families (33%) 
intended to birth at home, a rate higher than the general population, estimated at 
4.3%103. In addition, two families chose to opt out of newborn screening, and seven 
either had already declined, or planned to decline, some or all childhood 
immunisations.  
Demographic data for each participant is presented on the following page in 
Table 1. Each participant has a corresponding number in the first column (Interview 
#) which will be used to depict the origin of quotes used in the following thematic 




Table 1: Participant Demographics 
                                                          
g This is the method of administration initially chosen by parents, regardless of if they later changed their mind 
h At the time of the study interview 
i At the time of the study interview 






























1 Oral NZ 
European 
De facto 24 24 10 days 1 High School 5 Hospital Y Y 
2 Declined NZ 
European 
Divorced 44 22 13 years 3 Bachelor’s 6 Home N N 
3 Declined NZ 
European 
Engaged 23 21 16 days 2 High School 7 Hospital Y N 
4 Declined NZ 
European 
De facto 45 33 9 years 2 Bachelor’s 6 Home N N 
5 Declined NZ 
European 
Married 31 29 1year 5 
months 
1 Master’s 4 Home Y Y 
6 Declined NZ 
European 
Married 32 29 1year 1 
month 
2 Doctorate 2 Hospital Y Y 
7 Declined Russian De facto 43 34 9 months 2 Bachelor’s 6 Hospital Y N 
8 Oral NZ 
European 
De facto 26 20 3 days 2 High School 7 Hospital Y N 
9 Declined NZ 
European 
De facto 37 36 1 year 1 Trade cert. 3 Hospital Y Y 
10 Declined Dutch Married 31 25 3 years 4 
months 
2 Bachelor’s 8 Home Y N 
11 Oral Sinhalese Married 34 33 1 year 1 
month 
2 Doctorate 8 Hospital Y Y 
12 Declined English Married 31 31 1 month 1 Master’s 7 Home Y Y 
13 Oral American Married 34 34 1 day 1 Master’s 2 Hospital Y Y 
14 Declined Japanese De facto 38 34 6 days 2 Trade cert. 8 Hospital Y N 





Multiple themes representing important aspects of parental decision regarding 
vitamin K prophylaxis were present in the data gathered from these interviews. For 
ease of understanding and reading, these have been clustered into groups of 
subthemes under the headings of: parental beliefs and values, child welfare, and 
external influences. These themes are first illustrated with representative quotes in 
Tables 2, 3, and 4, and are described in full detail in the pages following. Many of 
these themes are interrelated and a number of quotes could potentially illustrate 
more than one theme. 
In addition, many parents brought up concerns about other perinatal and 





Table 2: Themes Related to Parental Beliefs and Values 
  
Theme Statement (interview number) 
Alternative 
Lifestyle 
“I personally would identify myself as more of an alternative person in general . . . 
I don’t always take drugs if I’m feeling bad, I’ll find something else or something 
more natural.” (8)  
“It’s always been his belief to keep things as natural as possible…He’s very 
strongly into letting nature take its course, right down to organic foods, soaps, 
conditioners and it goes as far as avoiding any sort of medical intervention.”(3) 
Natural Birth “I just didn’t want to interfere with nature that much.” (2) 
“It is quite natural and even though it’s quite overpowering it is very natural and 
your body can do it with or without you complying really.” (6) 
Questioning 
Necessity 
“I just don’t think it’s [vitamin K’s] hugely important otherwise it would’ve done it 
itself naturally.” (3) 
“Why treat something that you can’t see or there’s no outward sign that she’s 




“We’re not a “yes doctor” kind of family, we have some alternative perspectives to 
what mainstream medicine suggests.” (4) 
“Personally I would try and research it myself as much as I could and then I might 
still of course follow medical advice depending on the situation.” (10) 
Intervention 
Reduction 
“I was feeling that the least interventions as possible would have the best 
outcome.” (5) 
“I think minimal intervention in general about everything, especially when they’re 
little, and they’re so new, and their little immune systems are so new.” (8) 
Medicalisation of 
Birth 
“Birth is terribly over medicalised in the Western world.” (2) 
“In terms of healthy, normal pregnancy I think we probably do maybe intervene 
just a little bit too much.” (8) 
Breastfeeding “If baby really needed more Vitamin K then they’d get it from me.” (3) 
“If he didn’t get it through breastmilk naturally then that was another indicator 
that maybe it was not important to have or might be beneficial to not have it.” (5) 
Religion/Evolution “We believe that God created us and knew what He was doing, so why wouldn’t 
there be vitamin K in a baby when it’s obviously very necessary in an adult?” (6) 
“If it had been a big problem in the past then evolution probably would have 




Table 3: Themes Related to Child Welfare 




“For us it was the risks from [receiving] Vitamin K were higher because he was such 
a normal, easy birth.” (3) 
“For me it’s always about risk benefit, so the risk was the bleeding, but what are the 
risks of giving the intervention?” (4) 
Perceived Risk 
of Leukaemia 
“There’s one study out about leukaemia associated with intramuscular vitamin K 
and even though there is some evidence against that, the fact that it was in the 
literature was concerning.” (11) 
“I remember something like if we choose to give through injection there was a little 
side effect of some leukaemia. So for that reason I thought oral was better.” 
Amount Given 
via IM 
“There was also that sort of figure of two thousand times the dose of what an adult 
would have and it’s like well that’s really, really abnormal.” (2) 
“I knew that the vitamin K dose is quite high in one go so that led me to want to do 
the oral dose and spread it out as well.” (13) 
Pain  “We didn’t want to have her freshly born and then get stabbed up with a needle.” (1) 
“Oral is better because baby won’t cry, baby’s not getting any pain.” (15) 
Other Side Effect 
Concerns 
“I think we’re a bit naïve to think that is just because it doesn’t have leukaemia that 
there’s not some other spectrum of issues that can arise.” (2) 
“I think that children sometimes have allergy because of vitamin K.” (14) 
Perceived Low 
Risk 
“For most women, it means nothing. Not doing vitamin K does not mean your baby 
will likely die. It’s such a low percentage of babies that will be affected.” (2) 
“If it’s like that for lots of kids, if there’s no risk factor for them other than the fact 
that they’re being born, then maybe it’s the way it should be or it’s safe enough to 




“I would’ve reconsidered if there’d been anything abnormal in the labour or birth. 
(2)  
“Because of [baby]’s birth we decided the risks of not having vitamin K because he 
was bruised… were higher.” (3) 
Deciding 
Between Oral 
and IM  






Table 4: Themes Related to External Influences 
Theme Statement (participant number) 
Influence of 
Midwives 
“She [the midwife] said that it’s recommended for all babies but she told us she 
didn’t feel it was necessary in every case.” (3) 
“She [the midwife] had her own views but she probably didn’t tell us them she 




“I think when a doctor or a medical professional presents you with ‘this is 
available but it is not compulsory’ you think ‘well if it’s not compulsory then it 
can’t be actually necessary.’” (6) 
“If a medical professional tells us “this is needed” we’d probably take it without 
any qualms.” (6) 
“There was that one doctor that drove me nuts… she was basically making us 
feel like we were really bad parents because we didn’t do it.” (9) 
Information 
Sources 
“I found the pamphlets that they gave out from the hospital…they expected 
that you would do it. It wasn’t exactly giving you the option…if we’d only seen 
those pamphlets we probably would have just done it.” (3) 
“I tried to get my information from people that I thought were knowledgeable 
about this and also just books, I always checked out the studies at the back 
about it, so looked at the references and made sure that it wasn’t just 
someone’s opinion.” (10) 
Celebrities “Jacqui Brown…did a pregnancy book and there was quite a bit of information 
in there about Vitamin K…it was the book that made me wonder whether or 
not we even needed it, pretty sure in the book she chose not to give it [vitamin 
K] to her son.” (3) 
Family “Mum mentioned that when I had it when I was a kid that I had it orally… and 
she said that it all went fine…it didn’t make any difference…so it was good to 
have a first-hand experience” (8) 
“I wanted to check with my sister in law. I asked her, she said she also gave oral 
[vitamin K] for her kids.” (15) 
Friends “I remember asking other mums, so friends who’d had kids already, asking 





Parental Beliefs and Values 
The following themes were included under parental beliefs and values because 
they are representative of incompatibilities between deeply held parental beliefs 
and/or values and the administration of IM vitamin K prophylaxis to their baby.  
Themes include: beliefs from an evolutionary or religious perspective, an 
identity with an “alternative” lifestyle, and beliefs that birth is a natural process that 
we should not “interfere” with. 
Alternative Lifestyle 
For a number of participants, declining IM vitamin K prophylaxis for their 
newborn aligned with their own personal choices to live a self-described “alternative” 
lifestyle. This is illustrated in the following quotes: 
I was a little bit anti-conformist, can you tell? (Participant 2) 
It’s always been his belief to keep things as natural as possible…he’s 
very strongly into letting nature take its course. Right down to organic 
food, soaps, conditioners and it goes as far as avoiding any sort of 
medical intervention. (Participant 3 speaking about her fiancé) 
Our kind of social cultural perspective is one of holism and not blind 
faith in the medical system. (Participant 4) 
I personally would identify myself as more of an alternative person in 
general . . .I don’t always take drugs if I’m feeling bad, I’ll find 
something else or something more natural. I took a lot of natural 
remedies whilst I was pregnant. (Participant 8) 
For these parents, opting out of IM vitamin K fits within their worldview and is 
aligned with their personal beliefs. As one would expect, these beliefs guided many 
aspects of their lives, not just their decision about vitamin K (evidence for this is 
present in the answers given over many of the following sections).  
Natural Birth 
Participants that spoke of a natural birth often spoke of it in the context of 
having a “trust of nature” and believing that having as few interventions as possible 
would result in the best outcome. Such participants also often spoke of a preference 
for home and/or analgesia-free birth. Several quotes illustrate this theme: 
I just didn’t want to interfere with nature that much. . . I had a trust of 
nature which showed through in my births as well because they were 




I remember someone saying to me once ‘How do you get comfortable 
with the whole being at home and not being so afraid?’ and it’s like 
well to be honest I’m more afraid of walking through the doors of the 
hospital and being confronted with all the stuff that can happen there. 
(Participant 4) 
It is quite natural and even though it’s quite overpowering it is very 
natural and you know your body can do it with or without you 
complying really but I think the more we try to intervene the worse it 
goes often. (Participant 6) 
Right from the start I felt that birth is just a completely natural thing 
that women’s bodies are designed to do and I felt totally confident that 
I could do it without assistance or intervention and I think that I’m not 
massively keen on the hospital environment either…I’m very into the 
idea of the fourth trimester and I just wanted as peaceful as birthing 
experience for her as possible and for me being injected wasn’t part of 
that. (Participant 12) 
Again for these parents opting out of IM vitamin K for their baby fits with 
broader beliefs, this time concerning childbirth being a “natural process” with no 
necessity for medical intervention  
Questioning Necessity of Vitamin K Prophylaxis 
Parents who questioned the necessity of vitamin K prophylaxis did so for a 
variety of reasons. Some considered the research about VKDB to be out of date and 
thought it was not applicable in a modern clinical setting, or that VKDB is actually a 
problem created by medical interference at birth. Others considered that because all 
babies are born with low levels of vitamin K, there must be a reason for this, or it 
must not be important for them to have. 
The fact that they’re born with a low dose and that there’s a low dose 
available, it builds up as they get older, I just don’t think it’s hugely 
important otherwise it would’ve done it itself naturally. (Participant 
3) 
I come from a place of feeling that much of the data and research and 
stuff is done around medicalised birthing and based on historical 
situations where mothers and babies were separated a lot more. . . I 
would love to see a study on babies that have had absolutely no 
separation from their mothers and complete physiological birthing. 
What’s the incidence of Vitamin K deficiency bleeding? (Participant 4) 
Why treat something that you can’t see or there’s no outward sign 
that she’s lacking in vitamin K? . . . Vitamin K is like the only one that 





Others felt protected by having a ‘normal’ pregnancy and birth with a baby that 
did not show any sign of bruising.  
They were all completely normal births, I just didn’t see the point. 
(Participant 2) 
For a full term uncomplicated normal birth it didn’t seem appropriate 
but in another situation I totally thought it was a good option. 
(Participant 4) 
Furthermore some parents also felt that if they were eating a diet rich in 
vitamin K that prophylaxis was not needed. 
My diet was actually naturally high in vitamin K and I also take a 
supplement which had more than your daily allowance of vitamin K in 
it or more than your suggested daily intake of vitamin K in it so I 
figured that [baby] would’ve got vitamin K from me anyway in the 
womb so I didn’t feel she’d be deficient. (Participant 12) 
Questioning of Mainstream Medicine/Science 
A number of participants brought up that they have a scepticism, or questioning 
attitude towards mainstream medicine and the healthcare system as a whole. This 
was then reflected in their decision regarding vitamin K prophylaxis. Some 
participants stated that they felt it was best to do their own research as well as taking 
into consideration medical advice, rather than being totally against, or totally for, 
medical recommendations.  
We’re not a yes doctor kind of family. We have some alternative 
perspectives to what mainstream medicine suggests. (Participant 4) 
I think not just blindly accepting what doctors and science tell me. . . I 
like to do my own research find out my own stuff. If I agree with it yes, 
if I don’t that’s ok too, and so yeah I’m definitely a bit more open and 
alternative. (Participant 8) 
I don’t just trust any doctors saying something but I’ve had bad 
experiences with that anyway. Personally I would try and research it 
myself as much as I could and then I might still of course follow 
medical advice depending on the situation. (Participant 10) 
Intervention Reduction 
One of the most common reasons stated by parents for opting out of IM vitamin 
K was the idea of avoiding interventions not just in their pregnancy and labour but 




We wanted to where possible minimise the level of intervention that he 
needed. . . He has had so many interventions while he was in utero 
because of our risk history. So I think I’m glad that he had one less 
injection and one lower level of intervention than he might otherwise 
have had. (Participant 11) 
For me personally I was feeling that the least interventions possible 
would have the best outcome . . . every intervention has potential to 
lead to another intervention. (Participant 5) 
I think minimal intervention in general about everything, especially 
when they’re little, and they’re so new, and their little immune systems 
are so new. (Participant 8) 
The Medicalisation of Birth 
A similar theme to wanting to reduce interventions were parents feeling that 
birth is “over medicalised” and that we unnecessarily interfere with the process. 
Parents spoke of feeling that while some interventions are necessary, and justified, it 
is also sometimes a question of whether they are really needed, or are merely 
“convenient“ for the parents and/or healthcare staff.  
Birth is terribly over medicalised in the Western world. (Participant 2) 
I think it’s a balance. . . It’s whether it’s really needed or whether it’s 
just convenient. Like this time with my gestational diabetes I was on 
insulin injections but after the birth I had quite a few doctors tell me 
that they wouldn’t have considered me as a gestational diabetes case 
because my numbers were so borderline. . . like they probably didn’t 
need to interfere, I didn’t need the insulin. (Participant 3) 
There are times when you totally need the intervention. . . but I think 
in terms of healthy, normal pregnancy I think we probably do maybe 
intervene just a little bit too much. It’s such a natural thing it can 
definitely be done without all the extras. (Participant 8) 
I definitely would not judge any woman’s choice, however they want to 
give birth they should be allowed to and respected for that, but I do 
think there is quite a lot of fearmongering and the feeling that if you 
don’t birth in hospital you are risking yourself and your baby, I think 
that’s still very present. (Participant 12) 
Breastfeeding 
Another theme present in the interviews was the belief that if their infant really 
needed vitamin K, it would be present in, and passed through, their breastmilk. The 
majority of these parents knew that vitamin K was only present in low levels in 




parents considered breastmilk to be a whole food with everything present that their 
child would require.  
I suppose it goes right back to the natural side of things. If baby really 
needed more Vitamin K then they’d get it from me but I don’t think he 
needs it. . . I honestly believe that if baby really needed that high of 
dose of vitamin K then it would be available to them through the 
breast milk. (Participant 3) 
If he didn’t get it through breastmilk naturally then that was another 
indicator that maybe it was not important to have or might be 
beneficial to not have it. (Participant 5) 
We thought that Mother Nature supplies her with everything she 
needs. (Participant 7) 
Even orally my concern was that it’s still something other than breast 
milk and it’s something, artificial is possibly the wrong word, but it’s 
still something that is introduced to the infant rather than something 
the infant chooses to have. (Participant 11) 
Religion and Evolution 
Two families brought up similar points regarding their faith in human creation. 
Whilst one family spoke of this faith in terms of divine creation, and one spoke in 
terms of evolution, the main point for both families was their faith in the system of 
creation (by whichever means) and how if vitamin K was necessary for infants, they 
would be born with it.  
A belief that God created everyone and will have created us perfectly was stated 
by the family with the divine creation viewpoint. For this family, they believe that if 
God creates babies to have low vitamin K in their system at birth, there must be a 
reason why. This was illustrated by the following quote:  
We believe that God created us and knew what He was doing so why 
wouldn’t there be vitamin K in a baby when it’s obviously very 
necessary in an adult or in a person living in the world? (Participant 
6) 
The second family stated their belief that if all babies have lower levels of 
vitamin K in their system at birth, and a decreased ability of blood to clot, then it has 
probably evolved that way for a reason. They also stated that if VKDB has been a 




If it’s something that across the board kids do have a lower or babies 
born do have a lower level of then perhaps it’s kind of evolved to be 
like that for a reason ,maybe they need less clotting in their blood post 
birth. . . If it’d been a big problem in the past then evolution probably 
would’ve weeded out or found some way to deal with it. (Participant 
5) 
Child Welfare 
While parental beliefs and values were important factors for decision making, 
the majority of parents also brought up concerns regarding balancing the risks and 
benefits of administering vitamin K to their baby. These concerns related to: a 
perceived low level of necessity, potential pain, and worries about risks and side 
effects. The following section will describe common themes that parents brought up 
as objections to IM vitamin K prophylaxis and provide quotes to illustrate each 
theme.  
Perceived Risks outweigh Benefits 
All the participants who took part in the study spoke about their perception of 
the potential risks for their child if they received IM vitamin K prophylaxis. A number 
of participants went on to speak about how they weighed these risks against the 
benefits their child would receive.  
For us it was the risks from vitamin K were higher because he was 
such a normal, easy birth. (Participant 3) 
For me it’s always about risk benefit, so the risk was the bleeding, but 
what are the risks of giving the intervention? . . . There’s always the 
unknown and so the need to do something has to be strong enough to 
override those potentials from my perspective. (Participant 4) 
Concern about Amount Given 
One concern given by parents for opting out of IM vitamin K was the amount 
given in the injection.  
I think there was also that sort of figure of two thousand times the 
dose of what an adult would have and it’s like well that’s really, really 
abnormal. (Participant 2) 
For some parents, this high dose was one reason that they chose oral 
administration of vitamin K, as in their opinion it was preferable to spread out the 




I knew that the vitamin K dose is quite high in one go so that led me to 
want to do the oral dose and spread it out as well. (Participant 13) 
Pain 
For those who opted for oral prophylaxis, perceived pain for their newborn 
emerged as a very important factor, and was highlighted by the majority as their 
foremost reason for choosing oral over IM. 
We just wanted to go for the oral first… we didn’t want to have her 
freshly born and then get stabbed up with a needle. (Participant 1) 
I didn’t want my baby to have an injection as their first experience of 
being in the world. . . I just thought it’d be traumatising for her to have 
an injection as soon as she was born. (Participant 12) 
Oral is better because baby won’t cry, baby’s not getting any pain. 
(Participant 15) 
However, in contrast to the above, one mother questioned the idea of declining 
IM vitamin K to avoid causing pain, by comparing it to the experience of being born.  
Really they’ve just been through a much more painful traumatic 
experience than having a needle. I mean going through a birth canal is 
not going to be comfortable so really a needle prick that lasts a few 
seconds is much less and they probably don’t notice it, and they don’t 
notice it once they start feeding again which they do straight away. 
(Participant 6) 
Risk of Leukaemia  
Concerns about side effects or more serious harms were also significant factors 
for some parents. In particular, this was a perceived increase in risk for childhood 
leukaemia, which, as mentioned in the introduction, is a result of two studies from 
the early 1990s.  
There’s one study out about leukaemia associated with intramuscular 
vitamin K and even though there’s some evidence against that, the fact 
that it was in the literature is concerning. (Participant 11) 
I remember something like if we choose to give through injection there 
was a little side effect of some leukaemia. So for that reason I thought 
oral was better than injection. (Participant 15) 
Concerns of Other Side Effects 
In addition to leukaemia, other potential side effects were also of concern, both 




no known common side effects, they were also concerned about unknown things that 
could arise.  
I think we’re a bit naïve to think . . . just because it doesn’t have 
leukaemia that there’s not some other spectrum of issues that can 
arise. (Participant 2) 
I looked at a couple of, I can’t remember unfortunately the journals 
they were in, but a couple of medical studies on vitamin K and the 
potential side effects and that made me sure that I’ve made the right 
decision. (Participant 12) 
I think that children sometimes have allergy because of vitamin K. 
(Participant 14) 
Low Risk of VKDB 
For some parents, their decision not to give vitamin K was also based on how 
uncommon VKDB is. They felt that due to the already low risk, an intervention to 
further reduce it was not needed, or that they could reduce the risk through other 
means, such as a ‘natural’ birth and eating vitamin K rich foods. 
For most women, it means nothing. Not doing vitamin K does not 
mean your baby will likely die. It’s such a low percentage of babies 
that will be affected. (Participant 2) 
If it’s like that for lots of kids, like if there’s no risk factor for them 
other than the fact that they’re being born, then maybe it’s the way it 
should be or maybe it’s safe enough to risk not giving it to them. 
(Participant 5) 
However, parents were also understanding of the importance of vitamin K 
prophylaxis as a public health intervention, even if they chose to decline it for their 
own children.  
It didn’t feel appropriate for us to give it to our baby but I totally 
understand the perspective of ‘of all these babies some are going to get 
it and we don’t know which ones so let’s protect all the babies to 
reduce the risk’. (Participant 4) 
Changing Mind Depending on the Circumstances 
It is important to note that child welfare works both ways for IM vitamin K, and 
for three participants who originally opted out of IM vitamin K, following an 
instrumental birth, they opted back in. In these instances, they felt the risk benefit 




Because of [baby]’s birth we decided the risks of not having vitamin K 
because he was bruised . . . were higher. (Participant 3) 
Additionally, other parents who had declined vitamin K also spoke of 
potentially changing their decision if the birth required intervention. 
I would’ve . . . reconsidered if there’d been anything abnormal in the 
labour or birth. (Participant 2) 
So we thought given that that’s the way we’re designed, that’s the way 
we’re made, unless there’s a reason to intervene we’d just let their 
bodies do what they naturally would do and so we thought we 
wouldn’t intervene unless there was some reason why we’d need to as 
in they got cut during birth or bruised or had some accident. In which 
case we’re perfectly happy for it to be supplied. (Participant 6) 
That was our caveat that if there was anything that was either 
untoward in his presentation or in his delivery or in any other 
information that we had we would switch to intramuscular. 
(Participant 11) 
Deciding Between Oral and IM Vitamin K 
For two of the study participants who chose oral administration, they stated 
that for them it was not a question of whether or not their child would have vitamin K 
prophylaxis, but rather their main decision was deciding how to give vitamin K.  
I don’t see a reason why you wouldn’t want to give your kid vitamin 
K… their blood can’t clot without it. (Participant 1) 
I did do a bit of research myself and knew the possibility of bleeding 
into the brain, brain bleeds and things like that…so it was never really 
a question of not getting it done it was just how to have it done. 
(Participant 13) 
External Factors 
In addition to parents’ philosophies about pregnancy and birth, and their 
concerns about the risks and benefits of vitamin K, external factors that had 
influenced their decision were brought up. These will be described in the following 
section and include the influence of health professionals; information sources used to 
research vitamin K prophylaxis and VKDB; and celebrities, family, and friends.  
Midwifery Influences 
All parents talked about how their midwife had the greatest role in informing 




own research, but in a minority, the verbal information from the midwife, and any 
information pamphlets she chose to give, were all they based their decision on.  
Thirteen out of fifteen study participant first found out about vitamin K 
prophylaxis from their midwife and usually this occurred in the third trimester when 
participants were creating their birth plan. All participants felt that this was a good 
time to bring up vitamin K and most also felt that they had enough information 
provided to them by their midwife.  
I wasn’t quite aware about the vitamin K deficiency and the bleeding 
before my midwife educated me about that, she gave me a leaflet and I 
read through it and then I decided. (Participant 15) 
However, one participant in particular did not feel that she was provided with 
enough information from her midwife to make a decision. 
If I didn’t do my own research I wouldn’t have known anything about 
it. My midwife . . . she didn’t go into it without prompting and I 
probably wouldn’t have known anything about it without having done 
my own research. (Participant 8) 
Our data also shows that midwives sometimes share their own views of vitamin 
K prophylaxis, which are not always supportive.  
She [the midwife] said that it’s recommended for all babies but she 
told us she didn’t feel it was necessary in every case. (Participant 3) 
However, not all midwives did so: 
She [the midwife] had her own views but she probably didn’t tell us 
them she kept it quite neutral . . . She didn’t bias either way. 
(Participant 9) 
Nevertheless, the majority of participants spoke highly of their midwives and 
appreciated their support and the close relationship they were able to create.  
I feel that the midwifery system is very good because I feel a personal 
relationship with my midwife. A doctor will maintain a professional 
distance with her clients . . . but with my midwife I feel very personal 
with her and I had the choice of choosing a midwife who will come 
home and visit me so these kind of things make me feel the midwifery 






Whilst all participants had a midwife LMC, ten had planned hospital births and 
so had contact with a doctor at some point post-delivery. No parents described a 
medical professional as having an influence on their decision. However, a number did 
talk about how doctors were not supportive of their decision to opt out of IM vitamin 
K, and tried to change their mind.  
I had an experience when I was pregnant with my second child and I 
had to take my first child to a paediatrician and I was heavily 
pregnant and the doctor told me, because we explained that we hadn’t 
given Vitamin K to our first baby, and this paediatrician told me that I 
should be very afraid because of all the babies that she saw with 
haemorrhagic disease of the newborn which really pissed me off. I 
walked out of there just furious that this woman would tell a pregnant 
woman to be fearful. I thought that was a really poor approach. 
(Participant 4) 
There was that one doctor that drove me nuts . . . She was basically 
making us feel like we were really bad parents because we didn’t do it. 
(Participant 9) 
Another talked about how if a doctor says that an intervention is optional, such 
as vitamin K prophylaxis, then it makes it seem less important. 
I think when a doctor or a medical professional presents you with ‘this 
is available but it is not compulsory’ you think ‘well if it’s not 
compulsory then it can’t be actually necessary’ . . . but certainly if a 
medical professional tells us ‘this is needed’ we’d probably take it 
without any qualms. (Participant 6) 
One participant of Indian ethnicity compared the healthcare systems in New 
Zealand and India and spoke of how the patient autonomy-focussed system in New 
Zealand actually made it more stressful for them to make a decision. 
In India the doctors make a decision and they decide and they say that 
this is best for you and they do that but here they leave it to the choice 
of the patient. It’s good in one way but we were a little confused about 
whether to choose this or that and it was a little bit stressful for us to 
decide about it. (Participant 15) 
In addition, parents spoke about differing attitudes towards opting out of IM 
vitamin K between midwifery and medical staff. In general, midwives were described 
as much more accepting of their decision, whereas doctors were often described as 




medical and midwifery actions were noted to sometimes be confusing and are 
described below in a quote from participant 15.  
I felt that there was quite a lot of difference in opinion between the 
midwives and the doctors there, even among the doctors there were 
differences in opinion, but especially between the midwives and the 
obstetricians. (Participant 15) 
Information Sources 
The majority of participants had done their own research on vitamin K in 
addition to the verbal and written information provided by their LMC. A number of 
barriers to finding unbiased and factual information were noted, including that much 
of the information available to them online was from blogs and opinion-based pieces; 
and that a lot of the information available from sources such as the government, and 
hospitals, appeared biased towards vitamin K prophylaxis.  
I found the pamphlets that they gave out from the hospital . . . they 
expected that you would do it. It wasn’t exactly giving you the option . . 
. if we’d only seen those pamphlets we probably would have just done 
it. (Participant 3) 
We got one set of pamphlets that were standard government ones and 
kind of gave all the information and said your choice at the end but 
the way it was set out definitely suggested that you should do it. 
(Participant 5) 
A lot of it was opinion based, there didn’t actually seem to be that 
many with studies and stuff attached to them so it wasn’t easy to find 
them. A lot of them were just people saying they didn’t agree with it 
and stuff but I’d still read those because it is interesting to see why 
they didn’t. (Participant 8) 
Some participants spoke about ensuring that they were looking at information 
that had studies to back it up, or was peer reviewed, to ensure that what they were 
viewing was legitimate.  
I tried to get my information from people that I thought were 
knowledgeable about this and also just books, I always checked out 
the studies at the back about it, so looked at the references and made 
sure that it wasn’t just someone’s opinion. (Participant 10) 
I think I went to the most academic seeming or peer reviewed, I don’t 
think I was looking at things from online baby groups or anything like 





One participant spoke of information bias and how beliefs someone already 
holds will affect the manner in which they approach and view available information. 
You can find anything out there that’s going to go against something 
that’s beneficial, but on the same token you can find lots of 
information on things that maybe aren’t so good for them and it 
makes it seem good. I think it depends on the person and what they 
believe I guess. The information’s there it’s just a matter of how you 
look at it and what kind of research you do. (Participant 13) 
Celebrities 
One participant noted the influence of celebrities, or well-known people, on her 
decision regarding vitamin K. She read a baby book written by a New Zealand 
television personality which made her start thinking about whether she would 
choose vitamin K for her own child.  
It’s by Jacqui Brown she’s like a TV [personality], she did a pregnancy 
book and there was quite a bit of information in there about Vitamin 
K. . . That book made me think about it in the first place because I read 
that before I even spoke to the midwife about it and it was the book 
that made me wonder whether or not we even needed it. Pretty sure in 
the book she chose not to give it to her son. (Participant 3) 
Family 
A number of participants spoke about asking family members, particularly their 
mothers, for their opinion and about the method of prophylaxis they had chosen. 
While the parents I interviewed did not always think that this influenced their own 
decision, they did speak of feeling surer in their decision after knowing someone else 
who had had a healthy infant after opting out of IM vitamin K. 
Mum mentioned that when I had it when I was a kid that I had it orally 
. . . and she said that it all went fine . . .it didn’t make any difference 
and stuff like that so it was good to have a first-hand experience. (8) 
I wanted to check with my sister in law. I asked her, she said she also 
gave oral for her kids . . . that did not really affect my decision but I 
just wanted get a second opinion from her. (Participant 15) 
However, whilst the opinion of family members was asked, it did not always 
have an influence on the final decision.  
I talked to my mum about it. She actually doesn’t agree with me she 
thought we should’ve had vitamin K for both kids and definitely 





In addition to asking family members for their opinion on vitamin K, 
participants also spoke of asking friends who had previously had children.  
I remember asking other mums, so friends who’d had kids already, 
asking them if they’d done it and what their thought process was 
around it. (Participant 5) 
In a similar way to asking family members, the opinions of friends did not 
necessarily alter the decision that participants ultimately made.  
Concerns Regarding Other Perinatal and Childhood Interventions 
In addition to their decision about vitamin K, participants were also asked 
about other healthcare interventions that they had concerns about, particularly those 
for children and pregnant women. A number of concerns were brought up, and these 
often existed as part of a wider family hesitancy towards medical intervention. These 
concerns resulted in 7/15 participants planning to, or already declining 
immunisation; 2/15 declining newborn metabolic screening; as well as 5/15 opting 
for home birth.  
The following section will describe interventions and concerns raised by 
parents, in conjunction with quotes that illustrate these concerns.  
Immunisation 
In this study we had a high number of parents who had opted out of some, or all 
childhood immunisations (7/15). A number of concerns were raised, often centred on 
the safety of the vaccine, not wanting to ‘overload’ their system, and avoiding causing 
pain.  
I’m just not a huge fan of injecting any child with anything. I mean, my 
first was never immunised. (Participant 8) 
When I was pregnant I read the handbook from the ministry about 
vaccines . . . And I had many, many, questions about that and lots of 
things did not quite make sense to me. I also read some anti stuff and 
yeah I’m more inclined to lean towards the anti-vaccine but I’m not 
sure yet either. (Participant 10) 
I think that with something so little and so new that they can have too 
much at one time and so I’d already considered when the baby is due 





However, these views were not universal, and in contrast, some parents who 
had declined vitamin K prophylaxis were strongly in support of immunisation. 
They are both on track with their immunisations…Very keen on 
immunisation. Can get pretty angry with people who don’t immunise 
their kids basically. (Participant 6) 
We’ve had her first immunisations, I feel that’s important. (Participant 
12) 
Newborn Screening 
For newborn screening parental reasons for declining included that they didn’t 
feel it was necessary after a healthy pregnancy, and that they had a faith, or trust, that 
things would be normal.  
A large amount of it was the trust in the normal . . . there’s always risk 
in life and they’re incredibly low for the diseases that are screened for. 
(Participant 2)  
Our first born we didn’t actually do that we were again like this from 
that perspective of checking her for all these potential diseases didn’t 
quite fit where we were but with [second born] because complications 
had arisen and things had gone a bit askew it was a bit more like why 
is all this happening? . . . Yes let’s check if there’s anything else here 
that might be an underlying issue. (Participant 4) 
Folic Acid Supplementation 
One participant raised concerns regarding folic acid supplementation that were 
related to supplementation not being necessary for the entire population. 
Here we are fortifying foods for the whole population but actually 
some of us don’t need that stuff because we eat food that’s got it in it 
naturally. (Participant 4)  
Antenatal Classes 
Friends and social norms influence many aspects of a pregnancy, and we found 
that this included attending antenatal classes. The majority of study participants who 
brought up antenatal classes did not find them particularly useful but said that they 
attended them because they felt it was expected of them. 
Everyone’s going ‘you have to do antenatal classes so that you’re 
prepared’ but it didn’t actually prepare us for anything. . . We can’t do 
anything with our weekends now because we’ve got a baby but our 
very important two weekends before she was born was used up 





Two participants brought up concerns about the number of ultrasounds that 
pregnant women are given. These concerns were centred on potential long-term 
risks for both the mother and the child. They felt these had not been adequately 
researched.  
I think I’m quite firmly against ultrasounds unless that there’s 
something in the pregnancy that indicates that there is a reason for 
ultrasounds . . . to just routinely scan people and not knowing the 
actual long term possible risks like it hasn’t been researched properly 
from my understanding what the long term risks might be so therefore 
I think that it should not be used. (Participant 10) 
Well I definitely wouldn’t have wanted all the scans but I had to 
because . . . it was quite a complicated pregnancy but I would’ve 
preferred not to have ultrasounds. (Participant 12) 
Summary 
It is obvious from this chapter that there are a large number of reasons why 
parents choose to opt out of IM vitamin K – this is the first qualitative study to 
identify, and examine these. From the data it can be seen that many themes overlap 
and are interrelated. As a result, some quotes may be relatable to a number of 
themes, and not just those they are used to illustrate in the preceding chapter. For 
instance, a large number of the themes related to parental beliefs and values centred 
upon keeping the birthing process as “natural” as possible. This was the main value 
that underlied themes such as natural birth, intervention reduction and the 
medicalisation of birth.  
The core value of the themes related to child welfare was reducing any potential 
harm to the child. For some parents this meant that they chose oral prophylaxis over 
IM prophylaxis in order to prevent pain, and for others this meant that they wanted 
to avoid any perceived potential side effects of IM administration.  
Finally, the key concepts related to the external factors on parents’ decisions 
mostly related to the information that parents were given and how this information 
influenced their choice. A common concern brought up by parents was the need for 
unbiased, neutral information regarding vitamin K prophylaxis and how they often 




nationwide information programme similar to that in use in New Zealand for 
immunisation, and similar to that used in Australia for vitamin K prophylaxis107. 
In the next chapter, the discussion, the themes described above will be 
discussed in depth. The themes will be compared and contrasted to existing data 
regarding other childhood interventions such as newborn screening and 
immunisation. Following this, ethical questions that result from parents declining IM 
vitamin K prophylaxis will be discussed. These questions include: Should the choice 
to decline IM vitamin K for a newborn be accepted? And if accepted, how should 
health professionals act in order to advocate for what is believed to be in the “best 
interests” of the child while still maintaining an effective therapeutic relationship 





Chapter Four: Discussion 
 
 
Disagreements between parents and health professionals about a child’s 
medical treatment represent some of the most challenging issues in clinical 
paediatrics and bioethics. A significant body of literature exists concerning parental 
refusal of healthcare interventions108, 109, and a wide range of diagnoses and 
interventions have received attention, including refusal of: blood products by 
Jehovah’s Witness parents110; immunisation111; and newborn screening112. 
Interestingly, despite being one of the very first healthcare interventions 
recommended in infancy, administration of prophylactic vitamin K at birth has 
received relatively little attention. 
The following chapter will firstly discuss the data produced by this study, as 
well as place it in context with the existing literature, and evidence concerning 
parental decision making for similar childhood interventions. It will then examine the 
ethical concepts underlying parental decision making about vitamin K prophylaxis by 
employing a contemporary ethical framework.  
Parents’ Reasons for Opting Out of Intramuscular Vitamin K  
This project has been the first to examine parental reasons for opting out of IM 
vitamin K, the earliest, and one of the most prevalent public health intervention in 
early life in New Zealand. The key findings are the identified themes influencing this 
decision making process, including the importance of: underlying parental beliefs and 
values; concerns about risks/benefits; and external influences. A number of the 
themes were similar, or the same, as those described in a systematic review of 
qualitative research concerned with why parents opt out of immunisation, further 
emphasising the relationship between these two childhood interventions113.  
Underlying Parental Beliefs and Values 
As mentioned in Chapter One, a range of studies have now associated refusing 
IM vitamin K with factors aligned with parental, and/or health professional 
preferences and attitudes towards ‘natural birth’, including both local and 
international data2, 4, 5, 96. These preferences for a more ‘natural’ birthing experience 




nature; questioning of the medical field and the medicalisation of birth; living an 
‘alternative’ lifestyle; and avoiding interventions during birth and pregnancy. For 
many participants, these beliefs informed not only their views about pregnancy and 
childbirth, but many areas of their life. For example our data highlighted that many 
participants expressed hesitancy towards other perinatal interventions, with high 
rates of non-immunisation and declining newborn screening as well as opting for 
home birth compared to the general population (33% of participants chose a home 
birth compared to 3.6% of all babies born in the Otago/Southland area)103.  
Supporting the data from this study, many of the themes identified relating to 
parental beliefs and values have also been described in an analysis of qualitative 
research regarding parental attitudes and beliefs about immunisation. These similar 
themes include: distrust of the medical community, preferring to rely on a child’s 
natural immunity or alternative methods of protection, and religious reasons113. The 
identification of these similarities is important as the literature suggests that the two 
interventions are connected. Recent studies have shown that parents who decline IM 
vitamin K for their children at birth are fourteen times more likely to opt out of 
immunisations at eighteen months of age4, 6. 
Concerns About Child Welfare and Perceived Risk Associated with Prophylaxis  
From our data it is evident that parental perception of risk has a major effect on 
vitamin K prophylaxis uptake. This was described in a number of subthemes:  
Firstly, the perceived low risk of VKDB was a driver towards declining IM 
prophylaxis for parents. Study participants spoke of the low risk posed by VKDB to 
their child and how it seemed to be a “minor decision” compared to every other 
decision one has to make whilst pregnant. For some of these parents, the intervention 
was considered unnecessary and they also spoke of their perceptions that a “normal” 
delivery and/or pregnancy reduced their need for vitamin K prophylaxis, despite 
there being evidence that prevalence of low vitamin K levels does not differ between 
‘low’ and ‘high’ risk deliveries114. This opinion has also been seen in the attitudes of 
midwives as a study found that 45% of midwives thought that only babies ‘at risk’ 
should receive vitamin K prophylaxis. In this study, “at risk” infants included: 





The above perceptions of vitamin K prophylaxis not being necessary due to the 
low risk are perhaps best paralleled with parental beliefs regarding newborn 
screening programmes. The diseases screened for have a very low prevalence in the 
population and the majority of infants screened will not test positive, however the 
risk to the child of not identifying a disease early can be devastating. This is similar to 
vitamin K prophylaxis as although the risk of a child having VKDB is low, the 
resultant consequences can include death and significant permanent disability3. In 
such instances where the initial risk is low, but the resultant harm is significant, it can 
be hard to quantify the actual risk associated – a point that will be further discussed 
in the ethical analysis.  
Secondly, parental fears of perceived pain were shown by our data to be a 
common reason for opting for the oral vitamin K preparation. Such concerns 
regarding pain were hypothesised by a recent study to be a possible reason for the 
association between Asian or Indian ethnicity and declining IM vitamin K2. Due to this 
hypothesis, it was important to us to have a variety of ethnicities represented in our 
study cohort as we were interested in exploring any potential effect of ethnicity on 
this decision. Interestingly, supporting the aforementioned hypothesis, of the three 
participants in our study of Asian or Indian ethnicity, two raised concerns about pain 
from the injection as a reason for opting out of IM vitamin K. One of the mothers for 
whom pain was a concern stated that although their nuclear family isn’t “culturally 
bound”, she is “aware that in my family, children’s satisfaction and comfort is held as 
really important”. However this association is impacted by our small study numbers 
and further research would be needed to identify how applicable the association of 
pain and Asian or Indian ethnicity is in a wider context.  
Parents declining interventions in order to avoid causing pain to their child is 
also an important issue in immunisation and newborn screening113, 115, 116. Neonatal 
pain reduction is an expanding field, and evidence currently exists for a number of 
interventions that may be applicable to IM vitamin K prophylaxis. For instance, Leite 
et al. found that breast feeding before and after blood drawing for newborn screening 
decreased indices used to measure pain (facial actions, sleep-wake state, heart rate, 
and sucking)117, and Reis et al. found the use of a combination of sucrose, oral tactile 




the duration of crying in infants receiving multiple immunisations118. The 
effectiveness of these interventions for infants receiving IM vitamin K prophylaxis is 
unknown and could be explored in future studies. It is possible that parents who 
decline IM vitamin K due to beliefs about natural birth may also be opposed to using a 
bottle or sucrose to decrease pain as it is not in line with other associated ideals such 
as exclusive breastfeeding. However, these parents may be able to use a combination 
of the above two methods, such as breastfeeding and skin-to-skin contact or parental 
holding. Regardless, our interview data suggests that there is potential to increase 
parents’ acceptance, and possibly uptake of IM vitamin K prophylaxis if we are able to 
overcome the common barrier of avoiding pain.  
Thirdly, it is evident from this study that parental concerns about potential 
adverse effects are also contributing to IM vitamin K prophylaxis refusal. The most 
common adverse effect mentioned by parents was childhood leukaemia, which as 
described in the introduction, originated in the early 1990s from two studies that 
linked an increased rate of childhood leukaemia to IM vitamin K administration89, 90. 
Despite the findings not being replicated in subsequent work95, 119, 120, it is clear that 
they are still having an impact on parents’ decisions regarding vitamin K prophylaxis.  
These fears are not only confined to parents but also seen in a minority of 
health professionals, in particular midwives. This has been highlighted in a recent 
survey of midwifery and medical attitudes towards vitamin K in New Zealand96. This 
survey identified professional concerns regarding vitamin K, and found that 3.5% of 
midwives were concerned that prophylaxis was associated with cancer, 15.6% were 
concerned about other possible harms resulting from prophylaxis, and over 50% of 
midwives responded that they have concerns that naturally low vitamin K levels may 
have a physiological purpose we are unaware of. It is unknown how exactly these 
midwifery concerns affect the information that is given to expectant parents. Data 
from this study indicates that the majority of midwives make their patients aware 
that vitamin K is recommended for all babies, but then fully accept and support 
whatever choice is made, whether or not it aligns with this guideline. This is perhaps 
best illustrated in a quote from participant three which clearly shows the differing 




We made the decision not to have it. We still had about four different 
doctors and paediatricians and nurses question us ‘Do we realise what 
decision we’re making?’ I did feel pressured…They [the medical staff] 
did try and convince us to change our minds. My midwife was 
wonderful with that though she was very supportive of whatever we 
wanted to do. (Participant 3) 
However, generally high uptake rates of vitamin K prophylaxis in New Zealand 
suggest that it must be an issue that is regularly discussed and promoted by LMC 
midwives2, 6.  
The studies and ongoing concerns regarding IM vitamin K prophylaxis and 
leukaemia strongly parallel issues related to measles mumps and rubella (MMR) 
immunisation and autism. In 1998 a publication by Andrew Wakefield proposed links 
between the MMR immunisation, autism, and bowel disease. Unlike the work on 
vitamin K, Wakefield’s work was found to be falsified and was later retracted121, 122. 
However, like vitamin K, it resulted in an initial significant drop in uptake123, and now 
almost two decades later, a number of parents (not to mention many books, blogs 
and websites)still continue to report concerns about this link124. Strengthening the 
relationship between these two interventions further, are the two recent studies 
showing that parents who decline vitamin K prophylaxis are fourteen times more 
likely to decline immunisations 4, 6. 
External Influences 
External influences were also described by many parents as having an effect on 
their decision making, including the opinions of family members, the choices made by 
other pregnant women within their social circle, influences by the media and the 
internet, and as described previously, the opinions of medical and midwifery staff. 
Such psycho-social factors and media portrayal have been previously been shown to 
have effects on parental decision making for immunisation125-127, but prior to now no 
studies have linked this with vitamin K. As described by our data, these factors can 
influence parents both towards and away from an intervention. As an example, some 
participants spoke about a family member recommending vitamin K and how this 
influenced their decision towards it:  





While others spoke of how knowing someone who had declined IM vitamin K 
with no problems made them feel okay about declining as well: 
Mum mentioned that when I had it when I was a kid that I had it orally 
. . . and she said that it all went fine . . . so it was good to have a first-
hand experience. (Participant 8) 
As touched on earlier, the attitudes and values of a family’s health 
professional/s are also important influences on vitamin K prophylaxis uptake. 
Differing opinions between midwifery and medical staff regarding the important of 
vitamin K have been highlighted in a recent study showing that all medical staff but 
only 55% of midwives think that all babies should receive vitamin K96. As previously 
mentioned, our data shows that these differences in attitudes between medical and 
midwifery staff may result in differences in tone and content with what patients are 
being told. This is supported by a study from a Canada where midwife-assisted 
deliveries were eight times more likely to be associated with vitamin K refusal than 
physician-attended delivery4. Interesting, another study from New Zealand, where 
the vast majority of LMCs are midwives, found that opting for oral vitamin K was also 
associated with decreased LMC experience, per decade2, perhaps suggesting that the 
more experience a midwife gains, the more likely she is to follow Ministry of Health 
guidelines. Or, this might reflect a change in the way newer midwives are trained. 
The differences in attitudes between the medical and midwifery professional 
groups have previously been postulated to be partially accounted for by 
discrepancies in their guidelines96. For example, the current New Zealand Ministry of 
Health vitamin K guideline states that “it is the responsibility of the lead maternity 
carer (LMC) to discuss vitamin K prophylaxis and ensure that parents are aware of 
the recommendation that all babies should receive vitamin K prophylaxis”26. In an 
important contrast, the New Zealand College of Midwives published a consensus 
statement in 2000 which states that “midwives should ensure the woman is informed 
and supported to reach her own decision on whether Vitamin K is to be given intra-
muscularly, orally or not at all”128. These differences may both explain, and reflect 





On a positive note, the uptake rate of vitamin K prophylaxis in New Zealand is 
high, as over 92% of infants receive IM vitamin K2, and it appears clear that the 
majority of health professionals, whatever their field of practice, are discussing this 
intervention with their patients. Data on New Zealand midwives highlights this, as 
the majority consider that it is important that babies receive a dose of vitamin K96. A 
study published earlier in 2015 noted that 92.9% of infants born in the 
Otago/Southland region between 2009 and 2012 received IM vitamin K, 5.4% oral 
vitamin K, and only 2.4% no prophylaxis2. Whilst these rates of uptake are high, they 
are lower than comparable countries such as Canada and Australia. Uptake rates in 
Alberta, Canada have been published as 99.7% uptake of both IM and oral, and only 
0.3% receiving no vitamin K4, and rates in New South Wales, Australia have been 
published as 96.3% IM uptake, 2.6% oral uptake, and 1.2% receiving no vitamin K5. 
As mentioned in Chapter One, there is also potential evidence that IM prophylaxis 
rates in New Zealand are declining3. If these numbers are indeed representative of 
declining uptake of vitamin K prophylaxis, it is important to understand why parents 
are choosing to opt out. It is in this context that the data from this study is essential as 
being aware and empathetic of parents’ specific objections and questions means that 
clinicians are in a better position to overcome them. 
The above data and a potential link between healthcare provider attitudes and 
vitamin K prophylaxis uptake is supported by studies regarding immunisation that 
show strong associations between a recommendation of the intervention by a 
physician and subsequent uptake129, 130. There is also data regarding differing 
approaches that a physician may take and the effect that this has on uptake. For 
example, initiating vaccine recommendations with a presumptive approach (e.g. 
“Well, we have to do some shots”) rather than a participatory approach (e.g. “What do 
you want to do about shots?”) resulted in significantly lower odds of resisting vaccine 
recommendations131. It is possible that this knowledge of different approaches could 
be useful when recommending vitamin K prophylaxis, however the authors of this 
research also recognised that while using a presumptive approach may increase 
uptake in that session, it may not be beneficial for future healthcare decisions as 
parents do not have the opportunity to voice their concerns. In such instances, it has 
previously been noted (albeit in the context of newborn screening) that when parents 




future attitudes towards healthcare, thus making future consultations more difficult – 
a concept that will be explored in depth in the next section of this discussion.  
The Ethics of Parental Healthcare Decision Making 
In recent times there has been a shift in healthcare across the Western world, 
away from a model of medical paternalism, toward a patient-centred approach which 
places high value on a patient’s autonomy132. In New Zealand, the right of a patient to 
be fully informed, and the right to make an informed choice are recognised as two 
central tenets of healthcare133. This attitude also translates to children’s health where 
the concept of family-centred care, a model that incorporates shared decision 
making, is a central tenet of modern paediatrics134. In terms of ethics, children’s 
bioethics has now been recognised as a specialist field, although some of the key 
dilemmas have long been debated in general bioethics. The key advantage of viewing 
paediatric bioethics as a specialist field is the ability to highlight some of its common 
and fundamental ethical principles99. Perhaps the most central of these, at least in 
relation to very young children, are the concepts of parental autonomy and the best 
interests of the child. The following sections will discuss these concepts and how they 
may operate in relation to parental decisions concerning newborn vitamin K 
prophylaxis.  
Parental Autonomy 
The importance of parental autonomyk is widely recognised in both bioethics 
literature and in the practice of clinical paediatrics. In the majority of clinical 
situations it is assumed that parents naturally have the authority to make decisions 
for their children135, and various justifications for this authority have been described. 
Diekema argued that parental autonomy should be respected for a number of 
reasons97:  
1. Most parents care about their children and will therefore desire what is best 
for them, and make decisions which are beneficial to them. 
2. The interests of family members may conflict or compete and parents are 
usually better suited than people outside the family unit to compare such 
interests and make a final decision 
                                                          




3. Parents should be able to raise their children how they see fit, according to 
their own values and philosophies 
Salter also describes additional reasons why parents’ decisional authority 
should be respected135:  
 Parents are generally in the best position to know what decision the child 
would make if they were mature, and are the most knowledgeable about their 
child’s interests 
 Parents themselves are the ones who bear much of the primary burden and 
consequences of medical decisions that are made for their child 
Limits to Parental Autonomy 
For all of the above reasons, most ethical analyses, and clinical paediatrics, 
assume that a child’s parents are the people best suited, and most likely, to act in the 
best interests of the child97. However, this decision making entitlement is not 
absolute and parental autonomy is bounded by certain limits. A significant body of 
literature exists concerning the circumstances in which a health professional can 
ethically justify overriding parents’ medical decisions136, and New Zealand law states 
that when parents act in a manner where their child is being, or is likely to be 
harmed, the state may intervene98.  
Most contemporary frameworks permit parental discretion when making 
decisions unless there is a significant risk of harm to the child97, 99, 137. Examining 
parental refusal of IM vitamin K prophylaxis using such models highlights some 
interesting underlying questions, the first of these is whether it represents the type of 
parental decision that should be overridden? I will discuss this question using the 
framework of two commonly used models: The “Best Interests” of the Child, and the 
“Harm Threshold” Model, and one more recently developed model: The “Zone of 
Parental Discretion”.  
The “Best Interests of the Child”  
The “best interests” doctrine is used throughout the world in many contexts, 
including legal and bioethical discourse and clinical decision making135. Arguably one 
of the most important and influential documents regarding the treatment of children, 




concept of the “best-interests” of children. The UNCRC is the human rights treaty 
outlining the rights of children, including those of a civil, political, economic, social 
and cultural nature, and article three of the Convention states that “in all actions 
concerning children . . . the best interests of the child shall be a primary 
consideration”138. Additional to this, clinicians have traditionally thought in terms of 
a child’s best interests when deciding how to act when parents make a choice for 
their child that is not in line with their recommendations, and the “best interest 
standard” has become the prevailing ethical standard used to determine when 
interference is justifiable100. 
Acting in a person’s best interests has been defined as “acting so as to promote 
maximally the good of the individual”101 and the best interest standard has been 
defined as one in which “. . .a surrogate decision maker must determine the highest 
net benefit among the available options, assigning different weights to interests the 
patient has in each option and discounting or subtracting inherent risks or costs”102. 
Both definitions require the surrogate decision maker/s to always make the decision 
which is most favourable to the child. Therefore, if we examine the choice to decline 
newborn IM vitamin K prophylaxis using the best interests standard from a medical 
viewpoint, it could be argued that opting out is not in the infant’s best interests as the 
intervention reduces the risk of VKDB to close to zero with few potential side effects, 
thereby maximising their potential wellbeing3. However, the interview data 
presented in this thesis shows that many parents who opt out of IM vitamin K 
prophylaxis also believe that they are acting in their child’s best interests. Such 
parents place greater value on the avoidance of any potential side effects for their 
child, or on a completely ‘natural’ birth with few interventions, or on one of the other 
benefits they describe in the previous results section, than they place on the benefits 
gained from IM vitamin K prophylaxis. 
This conflict between two different ideas of what constitutes a child’s best 
interests illustrates two of the major criticisms of this model. The first being that in 
many situations it is difficult to precisely define and determine the course of action 
that is in the child’s best interests97. In the context of vitamin K prophylaxis, one 
could argue that IM vitamin K maximises the child’s wellbeing as it is the most 




K maximises the child’s wellbeing as it prevents any pain or distress to the newborn, 
despite potentially being not as effective3.  
The second point raised by this example is that the idea of “best interests” is 
inherently dependent on an individual’s values. All of the parents interviewed 
considered themselves to be acting in their child’s best interests and hence 
overriding their decision would involve assessing which values should be considered 
the most important and whose idea of the child’s best interests should prevail97.  
Other criticisms also exist as to why the best interest’s model is insufficient for 
the complexities involved with paediatric decision making. These include the inability 
to acknowledge the family as a unit and that it does not allow the parents to take into 
account interests other than those of the child who needs treatment; and that it is 
also an incredibly high standard to hold parents to, one that is generally not expected 
for other choices such as schooling or place of residence97, 99, 135. As a result of these 
criticisms, some ethicists have moved towards using the principle of harm and the 
idea of a ‘harm threshold’ to assist with clinical decision making97, 100, 139. 
The Harm Principle 
In the context of paediatric healthcare, the harm principle has been put forward 
as a test for justifying state intervention when parents refuse medical treatment for a 
child136. According to the harm principle, the feature of parental decision making that 
justifies interference is not that it does not align with the child’s best interest, but 
rather that the decision poses some harm to the child97. 
In his writing about the harm principle, Diekema summarises various 
suggestions about the nature of the harm threshold in order to try and identify the 
level of harm to be tolerated in parental decisions97. He states that parental decisions 
that do not significantly increase the likelihood of serious harm compared to other 
options should be tolerated, and that state intervention to overrule parents should 
only occur when a child is at significant risk of serious harm. He proposes eight 
conditions that must be met before state inference with parental decision making can 
be justified97: 





2. Is the harm imminent, requiring immediate action to prevent it? 
3. Is the intervention that has been refused necessary to prevent the serious 
harm? 
4. Is the intervention that has been refused of proven efficacy, and therefore, 
likely to prevent the harm? 
5. Does the intervention that has been refused by the parents not also place the 
child at significant risk of serious harm, and do its projected benefits outweigh 
its projected burdens significantly more favourably than the option chosen by 
the parents? 
6. Would any other option prevent serious harm to the child in a way that is less 
intrusive to parental autonomy and more acceptable to the parents? 
7. Can the state intervention be generalised to all other similar situations? 
8. Would most parents agree that the state intervention was reasonable? 
There is an evolving consensus among ethicists that harm is the central moral 
concept when judging the appropriate threshold for overriding in parents’ medical 
decision making136. Given this widespread acknowledgement that the harm principle 
is a more appropriate way of analysing parental decision making, I will now examine 
the parental decision to decline IM vitamin K prophylaxis with reference to 
Diekema’s eight criteria:  
1. By refusing to consent are the parents placing their child at significant risk of 
serious harm? 
VKDB is a relatively rare condition, with the classical version affecting 
approximately 1/1500 infants not given prophylaxis3. Hence one could state 
there is not a significant risk of harm by declining IM vitamin K prophylaxis. 
However, Diekema states that the salient point is whether a choice increases 
the likelihood of harm compared to other treatment options. As the likelihood 
of VKDB is reduced to near zero in the presence of IM prophylaxis, it could be 
argued that there is a significant increase in harm by declining and as 
approximately 50% of all late onset cases of VKDB result in disability or death, 




2. Is the harm imminent, requiring immediate action to prevent it? 
Again there is a degree of subjectivity in gauging whether or not any harm 
related to refusal of vitamin K is “imminent”. However, given that VKDB 
typically occurs within the first week to six months of life (unless the mother 
has been taking medication that interferes with vitamin K metabolism) it 
would be difficult to argue that vitamin K needs to be administered 
immediately to avoid harm.  
3. Is the intervention that has been refused necessary to prevent the serious 
harm? 
It is not possible to pre-determine which babies will develop VKDB and for 
each individual there is a relatively low chance that they will have VKDB, even 
without prophylaxis. Thus it would be difficult to argue that the intervention is 
necessary to prevent the serious harm, but it does reduce the risk.  
4. Is the intervention that has been refused of proven efficacy, and therefore, 
likely to prevent the harm? 
The efficacy of newborn vitamin K prophylaxis in preventing VKDB has been 
firmly established140 
5. Does the intervention that has been refused by the parents not also place the 
child at significant risk of serious harm, and do its projected benefits outweigh 
its projected burdens significantly more favourably than the option chosen by 
the parents? 
IM vitamin K prophylaxis does not place the child at significant risk of serious 
harm and its projected benefits clearly outweigh its projected burdens, 
although some authors do argue that a small risk of an increased likelihood of 
childhood leukaemia cannot be excluded53.  
6. Would any other option prevent serious harm to the child in a way that is less 
intrusive to parental autonomy and more acceptable to the parents? 
There are two options of administration of vitamin K prophylaxis (IM and 
oral) so it may be that parents who have declined IM prophylaxis would find 
oral prophylaxis more acceptable. Given that oral vitamin K provides similar 




(including that all three doses are received) this may be an acceptable 
alternative to parents who are concerned about pain141.  
7. Can the state intervention be generalised to all other similar situations? 
The state intervention in newborn vitamin K prophylaxis could potentially be 
generalised to all births.  
8. Would most parents agree that the state intervention was reasonable? 
There is widespread acceptance of IM vitamin K prophylaxis with over 90% of 
parents choosing to give this to their children, so arguably they find the 
intervention itself reasonable2. Whether they would agree that state 
intervention to overrule parents who wish to decline is reasonable is 
unknown.  
While there may be debate about some of the above criteria in relation to IM 
vitamin K prophylaxis it is clear that all eight are not met. It follows then that under 
the Harm Principle a parental decision to opt out of IM vitamin K prophylaxis would 
not normally constitute a decision that is justifiably overridden. Exceptions may 
however exist, including for preterm infants, or those with cholestatic disease, as they 
may be particularly vulnerable to developing a functional vitamin K deficiency142.  
The “Zone of Parental Discretion” 
I turn now to a third framework for paediatric healthcare decision making. The 
Zone of Parental Discretion is a concept developed by ethicists at the Royal Children’s 
Hospital Melbourne (Melbourne, Australia) as a tool to help consider if decisions 
made by parents should be accepted, even when they are not seen to be in the child’s 
best interests by medical staff99. The Zone of Parental Discretion extends the idea of 
the harm principle to all situations of disagreement between parents and clinicians, 
not just those where state intervention is being considered. The key idea is that 
clinicians can accept parental decisions that are suboptimal for the child, so long as 
the decisions do not involve probable significant harm to the child. 
The use of the Zone of Parental Discretion consists of two stages of 
consideration: the first being the harm from the parents’ decisions and the second 
being the harm from overriding the parents’ decision. Stage one is similar to the harm 




probable significant harm to the child. If the decision will not result in probable 
significant harm, then the decision lies within the Zone of Parental Discretion. Stage 
two requires determining the effects of overriding the parental decision and 
determining whether this would in fact cause greater harm than the harm expected 
from the original decision.  
The Risk of Serious Harm Associated with Refusal of IM Vitamin K 
The issue of what constitutes probable significant harm to a child is at the heart 
of both Diekema’s harm principle and the Zone of Parental Discretion. Some 
situations in paediatric care clearly require intervention, such as when parents make 
a decision that will definitely result in the child’s death when another option exists 
that would cure them. Conversely, some situations clearly do not require intervention 
and the parents should be able to make decisions at their discretion, such as when 
there is a range of treatment options and none offer any obvious advantage over the 
others. However, refusal of IM vitamin K prophylaxis poses a difficult question for 
these models: the risk of harm occurring from refusing vitamin K is relatively low, but 
the consequences may be very serious. With any threshold or zone there are likely to 
be “grey areas” around the edges and it seems that vitamin K prophylaxis may fall 
within such an area. Refusal of newborn screening poses similarly low levels of risk of 
serious harm112. 
The Risk of Overriding Parental Refusal of Vitamin K 
The second stage of the Zone of Parental Discretion is particularly important in 
vitamin K prophylaxis as how physicians react to this first healthcare decision may 
‘set the scene’ for any future interactions those parents have with the healthcare 
system. This is because healthcare decision making is a long-term process and it is 
important that consideration is placed upon not just how an action will affect the 
current doctor/patient relationship, but also how it will affect a patient’s (or in this 
case the parents’) views of healthcare in the future. Newson notes that forcing 
parents to make a decision that opposes their personal beliefs may polarise their 
views towards healthcare112, and as vitamin K prophylaxis is often the first medical 
choice the majority of parents will make for their newborn, it may be particularly 





Concern about the future risks to the doctor/patient relationship and how it 
will affect conversations about healthcare decisions in the future may contribute to 
the current reluctance to overrule parents who opt out of IM vitamin K prophylaxis.  
Current Practice 
As reflected in most information sheets for parents and policy documents26, 143, 
144, it has become accepted practice to permit parental refusals of IM Vitamin K 
prophylaxis. This is likely based on the concepts noted above, that it is difficult to 
reach a consensus regarding whether refusal constitutes significant risk of serious 
harm, and that the harm associated with overruling parents may be substantial. 
Similar arguments about accepting parents’ decisions, even when they are contrary 
to medical recommendations, have been made regarding newborn screening, another 
intervention in the neonatal period which carries a similar level of risk112.  
How Should Health Professionals Respond When Parents Decline Vitamin K? 
Despite the evolving consensus among ethicists that harm is the key ethical 
concept when judging the appropriate threshold for state intervention in parents’ 
medical decision making, there is much more controversy regarding how to respond 
to disagreements that fall around the margins of that threshold136. It remains unclear 
how health professionals should respond when they think a parent is making a 
decision that is significantly suboptimal from the child’s perspective, but does not 
involve the serious, imminent harm that justifies state intervention. In such cases, is it 
always ethically appropriate for health professionals to question parental decisions, 
or try to persuade a parent? There is significantly less literature available concerning 
how such situations should be managed. None of the models discussed above give 
explicit direction on this as they are focussed on the context at the time of the 
decision, rather than a longitudinal approach that acknowledges the long term nature 
of the doctor/patient (or parent) relationship. As a result it is at this stage that our 
interview data and knowing specific reasons why parents choose to opt out of IM 
vitamin K prophylaxis is useful.  
Taking a tailored approach to consultation depending on the parents’ reasons 
for hesitancy is one option. This has been previously recommended for 
immunisation145, an intervention similar to vitamin K prophylaxis, and may be 




prophylaxis. For example if the parents’ major concerns relate to child welfare, 
specific steps could be taken to educate and reassure parents, and/or pain 
management methods could be employed. Another study involving parents who were 
hesitant to immunise showed that when parents are given specific time to voice their 
concerns at a specialist immunisation clinic the likelihood of immunising their 
children increases146. Measures such as these, coupled with an acknowledgement that 
the parents’ decision, while not optimal from a medical perspective, falls within their 
discretion, arguably both respects parental autonomy, and enables the health 
practitioner to act in an ethically appropriate and professional manner. 
If underlying parental beliefs and values are the major determinant in a 
parental decision to opt out of vitamin K, further education concerning child welfare 
may be less helpful. It is important that such parents do not feel pressured to make a 
decision contrary to their personal wishes because as mentioned earlier, this may 
polarise their future attitudes towards healthcare112. This is reflected in one paper 
which showed that some methods employed by clinicians to convince parents to 
immunise can actually ‘backfire’ and further decrease intent to immunise147. It has 
also been argued in the context of newborn screening that while some degree of 
encouragement is important, there is a definite difference between advocacy, and 
forceful attempts to coerce parents112. In such instances, a clear acknowledgement of 
the moral weight accorded to parents as decision-makers for their child, coupled with 
continued explanation that healthcare professionals remain concerned about the 
potential harm to the child, may help maintain a therapeutic alliance with the family.  
In this section we have made some preliminary remarks about how to manage 
parental refusal of IM vitamin K, a decision that while suboptimal from the child’s 
perspective, does not appear to reach an appropriate threshold of “serious imminent 
harm” that justifies state intervention. However, this area remains significantly 
under-studied and we suggest the need for further research both in relation to 
vitamin K specifically, and “sub-optimal” decisions more generally. 
Study Strengths and Limitations 
The use of qualitative research methodology and thematic analysis was a 
specific strength of this study as it enabled in-depth exploration of themes and 




having a large percentage of participants opting to give birth at home (5/15) 
compared to the regional average of 4.3% meant that we were able to elucidate the 
concerns of this group particularly well103. As participants for studies involving 
maternity care, including the main data on uptake of vitamin K prophylaxis, are often 
drawn from hospital records, those who birth at home are excluded unless they end 
up in hospital. As a tendency towards “natural birth” appears to be an important 
determinant of vitamin K uptake, including the views of those who birth at home is 
vital. In fact, if we allow for this effect, and a resultant lower uptake of vitamin K 
prophylaxis for infants born at home, the total uptake rates of vitamin K prophylaxis 
around the country may be even lower than currently thought  
As always with studies of this nature, sample size is a weakness. While we 
cannot claim that the results of this study include all possible factors that influence 
parents’ decisions regarding vitamin K, the themes identified were relatively 
consistent in that common themes were brought up time and again without new ones 
appearing in the final interviews. Additionally, despite the smaller sample size, we 
had a large number of ethnicities represented (eight). This was vital as certain 
ethnicities have previously been associated with opting out of IM vitamin K, and we 
were interested in any effect that ethnicity may have on parental choice. Ideally 
future research on this would focus even more closely on these groups, something 
that was not possible in the time frame allowed for a BMedSc(Hons) project 
Due to this study using qualitative research methodology which examines views 
within a particular context (in this case only one DHB in New Zealand – albeit the 
largest geographically), generalisability of these findings to another time and/or 
place may be problematic. Future research looking at national datasets on uptake 
would be beneficial, however this is hampered by the fact that the Ministry of Health 
(MoH) does not routinely collect data on the uptake of vitamin K prophylaxis, despite 
it being a universally recommended intervention. Continued efforts to encourage the 
MoH to collect this data are required, particularly given that concerns about safety 
continue to be raised in our data, and by others96.  
However, despite the potential issue of generalisability, the themes identified in 
this study are consistent with those brought up by parents declining similar 




as a springboard for additional semi-quantitative research that can explore the issues 








Parental acceptance or refusal of IM newborn vitamin K prophylaxis is the first 
healthcare decision most families make for their newborn and is also an indicator of 
the uptake of subsequent health interventions. This work is significant as it has been 
the first study to closely examine factors that influence parental decision making and 
lead to a decision to opt out of IM newborn vitamin K prophylaxis. The key findings 
are that while there are a large variety of reasons why parents decide to opt out of IM 
vitamin K, they can be grouped into three main themes: parental beliefs and values, 
child welfare, and external factors.  
By knowing what influences parental decision making regarding vitamin K, 
health professionals can not only gain a deeper understanding of parents’ concerns, 
but may also be able to provide interventions that will potentially maintain and/or 
improve uptake. However, it is important to consider how such interventions will 
impact the doctor/patient relationship. Parental beliefs and values may remain 
steadfast despite intervention by health professionals, however taking the time to 
understand parents’ reasons may help build the relationship and provide 
opportunities for discussions in the future about other health interventions. Parental 
concerns regarding child welfare, and the external influences on decision making may 
be targets for intervention – particularly the management of pain from IM vitamin K 
and understanding attitudinal differences between health professionals and the 
impact that these may have on parental decision making. Further exploration of other 
factors that have been identified to impact on uptake (such as ethnicity) also appears 
to be important, particularly given the increasingly multicultural nature of New 
Zealand’s population.  
Ethical analysis of parental refusal of newborn IM vitamin K prophylaxis 
highlights that while this decision probably falls within a “Zone of Parental 
Discretion”, it is close to the margins. It is therefore suggested that in practice health 
professionals should attempt to encourage parents to choose vitamin K for their child 
but should not be coercive. An understanding of parental reasons for hesitancy is 
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Appendix 1: Interview Guides 
Questionnaire - Vitamin K choices of New Parents  
Name/s:     Ethnicity: 
DOB:       Address: 
Occupation:     Highest educational level:    
Marital status:      Number of children of father: 
Gravida:     Parity:  
Babies DOB:     Type of birth: 
Gestation at birth:    Birth weight: 
LMC: midwife / doctor    Vitamin K: Oral/Declined  
Intended place of birth:  
We’re interested in finding out about how parents decide whether or not to give vitamin k to 
their baby 
Can you tell me about your Vitamin K decision, starting from when you first found out about 
Vitamin K? 
How did you come to this decision and what were your reasons for opting for the method of 
vitamin K that you chose? 
1. Information 
 When and how did you first become aware of vitamin k? 
o E.g. midwife, antenatal class, brochure, pregnancy book, own research 
 What information were you provided with about Vitamin K? 
o Was any further information suggested to you? 
 Did you talk to anybody other than your LMC about Vitamin K? 
o Who? Suggested by midwife, or found yourself? 
 Did you seek out extra information yourself? 
o i.e. website, book, pamphlet, etc. 
 Which sources of information did you use in your decision about vitamin K? 
o Hospital pamphlet 
o Womens Health action group Pamphlet on vitamin K 
o Antenatal classes 
o Healthcare professional – midwife/LMC/GP/O&G, etc. 
o Internet, if so which site. 
o Book, if so which one 
o Other mothers/fathers/friends/family members 
o Other (ask what) 
 Do you feel you were given or had access to enough information about Vitamin K? 






 What are your concerns about giving vitamin K by injection/orally?  
 Are there any specific issues related to vitamin K from your or your family’s perspective? 
o cultural / religious / family / personal 
 Did you feel any pressure whilst making your choice?  
o i.e. from midwives, doctors, nurses, etc. 
 
3) After the choice 
 How do you feel about your decision now? 
 How does the other parent feel about the decision now? 
 Have you tried any alternative means to reduce the risk of vitamin K deficiency bleeding 
in your baby? 
o i.e. naturopathic products, increasing maternal intake, etc. 
 If you have other children – did they receive vitamin K? 
 Are there any other health interventions for your baby you have concerns about? 
o Do you plan to immunise your child? 
o Do you plan for your child to undergo newborn metabolic screening? 
Do you have any other comments you would like to make? 
 






Vitamin K choices of Parents – Extra Questions 
1. During the interview we spoke about information sources you used and you mentioned 
that you searched about vitamin K on the internet and looked it up via other methods.  
 Can you tell me in what ways the websites and other sources and the information you 
found there influenced your decision? Did they promote or oppose vitamin K? 
 In what ways did media/other information sources have an influence on your decision 
about vitamin K? Did it promote or oppose vitamin K? 
 
2. What influence did your partner have on your decision about vitamin K? Did they 
promote or oppose vitamin K? 
 
3. What influence did your family have on your decision about vitamin K? Did they promote 
or oppose vitamin K? 
 
4. What influence did your friends or other pregnant women have on your decision about 
vitamin? Did they promote or oppose vitamin K? 
 
There are often many healthcare professionals involved in pregnancy.  
1. How did you choose your LMC?  
 Do you consider that they have similar values to you? 
 Is it important that they do (have similar values)? 
 
2. Can you tell me if any doctors involved in your care: 
 Knew of your decision to opt out of IM vitamin K? What was their reaction?  
 Did they influence your decision? How? 
 Did they attempt to further educate you on vitamin K?  
 Did they attempt to change your mind? How? 
 Did they state to you that vitamin K is recommended for all babies? 
 
3. Can you tell me if any midwives involved in your care: 
 Knew of your decision to opt out of IM vitamin K? What was their reaction?  
 Did they influence your decision? How? 
 Did they attempt to further educate you on vitamin K?  
 Did they attempt to change your mind? How? 
 Did they state to you that vitamin K is recommended for all babies? 
 




 Knew of your decision to opt out of IM vitamin K? What was their reaction?  
 Did they influence your decision? How? 
 Did they attempt to further educate you on vitamin K?  
 Did they attempt to change your mind? How? 
 Did they state to you that vitamin K is recommended for all babies? 
 
5. Can you tell me if any other practitioners (naturopaths, homeopaths, chiropractors, etc.) 
involved in your care: 
 Knew of your decision to opt out of IM vitamin K? What was their reaction?  
 Did they influence your decision? How? 
 Did they attempt to further educate you on vitamin K?  
 Did they attempt to change your mind? How? 
 Did they state to you that vitamin K is recommended for all babies? 
A number of parents have said that their decision for vitamin K would change depending on the 
risk of Vitamin K Deficiency Bleeding posed to their child. If this applies to you: 
 Can you describe the level of risk needed for you to give your child prophylactic vitamin 
K? 
 What do you think would change this risk? (i.e. mode of birth, instruments used at birth, 
etc.) 
 































Appendix 4: Poster 
Presented at the Perinatal Society of New Zealand Scientific Meeting. July 3 2015. 
